rfhg_24203.1

Basic information about the TSS

---

TSS ID: rfhg_24203.1 Species: human Chr: chr2		Start: 26034529 End: 26034535 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3100788,EH38E1981687)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC000896:0 GeneID: 10890 HGNC/MGI_ID: HGNC:9759 UniProt_ID: Nearer transcript ids and distances: AF086917:-13 AF106681:-13 CR457303:74 AB529109:74 EU831733:74 EU831649:74 HQ447911:74 AF297660:74 AF498945:74 AF091032:134 AK023223:-419 ENST00000495146.5:-422 AL136650:-424 ENST00000264710.5:-445 NM_016131.5:-445 view more...

Gene_name: RAB10, member RAS oncogene family Gene_symbol: RAB10 Gene_synonyms: Gene_source: HGNC:9759

TATA-Box annotation

---

Distance to TSS:	448
Nearest PromoterID:	NM_016131
Entrez ID:	10890
Nearest Unigene:	Hs.467960
Nearest Refseq:	NM_016131
Nearest Ensembl:	ENSG00000084733
Gene Name:	RAB10, member RAS oncogene family
Gene Alias:	-
Gene Type:	protein-coding
CpG%:	0.166667
GC%:	0.714286
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RAB10 p2@RAB10 p3@RAB10 p4@RAB10 p5@RAB10 p6@RAB10 p9@RAB10
Sample		p1@RAB10	p2@RAB10	p3@RAB10	p4@RAB10	p5@RAB10	p6@RAB10	p9@RAB10
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	85.91	10.91	1.36	0.78	0.00	1.36	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	104.19	10.72	1.62	1.82	0.61	1.82	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	90.66	8.29	0.77	1.74	0.39	1.93	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	95.85	14.14	0.00	0.62	0.21	1.66	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	101.23	14.62	0.67	0.67	0.90	0.90	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	83.53	13.18	1.36	1.94	0.19	2.13	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	81.05	15.03	1.74	2.61	0.65	2.18	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	91.80	13.32	0.24	0.48	0.48	1.21	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	91.90	13.68	0.85	1.71	0.43	1.71	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	69.56	12.75	2.32	0.58	1.74	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	84.48	12.13	1.21	2.83	0.00	1.62	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	73.99	17.89	2.03	1.22	0.41	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	24.34	2.90	1.13	1.45	0.32	1.13	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	18.94	2.41	0.45	1.65	0.60	1.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	22.61	1.98	0.66	0.88	0.88	1.76	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	14.08	4.28	0.50	3.77	0.50	3.02	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	18.13	1.97	0.00	1.53	0.44	2.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	18.98	2.53	0.42	4.22	0.00	2.11	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	19.19	7.46	0.00	0.53	0.00	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	24.52	1.81	0.15	1.50	0.30	0.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	24.32	2.67	1.74	1.34	0.53	0.67	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	22.79	1.73	0.17	1.38	0.17	1.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	21.84	2.20	0.52	1.16	0.13	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	24.02	2.18	0.24	1.94	0.24	0.73	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	22.96	3.35	0.26	2.06	0.77	1.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	22.47	2.85	0.00	0.63	0.32	0.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	18.13	2.20	0.55	2.75	0.55	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	24.75	3.54	1.18	1.41	0.24	1.65	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	27.62	2.26	1.29	0.97	0.81	0.48	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	29.14	1.99	0.72	0.90	0.72	0.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	22.61	3.77	1.26	2.72	0.42	1.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	19.93	3.32	0.39	1.37	0.20	2.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	21.74	3.17	0.42	2.95	0.63	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	18.31	3.46	1.48	1.81	0.49	1.32	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	21.88	3.55	1.31	2.06	0.37	2.43	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	24.53	3.45	1.34	2.49	0.00	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	21.66	3.47	1.02	2.04	0.41	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	17.33	3.22	1.61	1.21	0.20	2.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	19.99	3.51	1.35	1.35	1.62	1.35	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	30.97	2.64	0.72	1.92	0.72	1.44	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	28.94	2.82	1.65	2.12	0.94	0.71	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	20.93	3.07	0.44	1.76	0.88	2.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	19.61	3.80	1.27	0.84	0.21	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	21.50	3.67	2.10	2.45	1.05	2.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	20.68	3.21	2.01	2.01	1.61	1.81	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	26.52	4.42	2.33	2.56	0.70	4.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	21.83	3.84	0.48	1.92	0.48	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	21.16	2.98	1.79	0.60	0.30	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	22.98	5.51	0.96	3.11	1.20	1.91	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	16.38	5.86	2.02	1.01	1.01	1.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	18.86	4.51	1.23	2.05	0.82	1.43	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	27.35	5.34	2.22	3.11	0.44	2.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	111.94	41.98	13.99	0.00	0.00	27.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	24.13	6.03	2.84	4.26	1.42	1.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	23.86	5.30	1.33	2.65	0.66	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	36.91	8.39	3.36	13.42	1.68	38.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	19.75	5.97	0.92	4.59	1.38	1.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	29.17	5.83	1.94	5.83	1.62	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	27.62	5.78	3.85	5.14	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	33.63	3.77	4.71	5.66	0.63	2.83	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	22.56	2.12	1.41	4.23	0.71	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	24.11	5.61	2.80	10.09	2.24	1.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	19.90	4.78	0.80	12.74	0.00	10.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	22.08	4.76	1.36	4.76	1.36	2.72	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	26.97	5.85	1.62	5.52	1.62	3.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	25.56	4.61	3.19	4.97	1.42	3.55	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	96.98	16.16	0.00	0.00	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	47.38	31.59	7.90	7.90	0.00	47.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	38.03	3.41	3.90	4.39	0.98	3.90	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	31.24	3.97	2.98	4.96	2.48	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	36.12	1.88	1.41	2.81	2.35	2.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	27.82	3.97	1.32	3.64	1.66	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	29.39	4.02	1.55	2.47	0.62	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	29.05	4.89	3.67	4.28	0.61	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	48.62	2.06	3.96	1.27	0.63	0.48	0.79
Adipocyte - breast, donor2	11327-117E4	47.81	1.76	2.57	2.57	1.28	1.93	0.32
Adipocyte - omental, donor1	11473-119C6	45.29	2.04	2.29	1.15	0.38	0.51	0.25
Adipocyte - omental, donor2	11474-119C7	36.63	0.75	2.99	3.74	0.75	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	30.48	0.67	1.00	1.34	0.33	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	36.37	1.28	2.55	3.19	1.28	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	27.49	0.00	1.10	2.20	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	46.97	2.71	1.35	0.00	0.90	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	44.31	0.35	0.87	0.52	0.17	0.17	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	94.66	4.11	3.72	0.59	0.59	0.59	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	44.01	1.80	2.57	0.77	0.77	0.51	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	76.38	2.23	3.62	0.84	1.12	0.28	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	54.08	2.94	3.53	0.59	1.18	0.59	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	81.72	1.53	2.98	0.48	0.24	0.56	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	59.06	1.29	3.23	1.29	0.32	0.97	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	41.06	2.13	1.07	0.53	1.07	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	37.28	2.23	1.11	0.56	1.67	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	61.97	1.66	2.50	0.83	0.00	0.00	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	60.78	4.27	3.27	0.50	0.75	0.25	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	47.78	0.98	2.62	0.33	0.33	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	42.32	0.91	1.22	0.61	0.61	0.00	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	49.06	3.98	1.10	0.66	0.22	0.88	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	20.08	3.94	1.43	0.00	0.72	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	16.77	0.00	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	53.07	4.32	2.70	0.72	0.54	0.36	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	40.16	0.00	1.67	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	41.29	1.85	1.23	0.41	0.21	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	47.83	1.03	2.52	0.46	1.14	0.34	0.11
Anulus Pulposus Cell, donor2	11463-119B5	41.14	2.94	4.65	1.96	0.24	0.98	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	41.78	4.04	2.25	2.25	0.45	1.35	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	43.41	3.47	4.78	0.00	0.87	2.17	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	36.38	2.14	0.00	10.70	0.00	6.42	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	55.00	1.49	3.29	1.49	1.49	1.20	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	48.06	6.32	0.00	0.00	3.79	3.79	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	29.04	3.30	1.98	2.64	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	45.48	1.62	2.92	1.30	0.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	46.60	3.88	0.49	0.97	0.49	2.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	30.29	4.16	1.19	2.38	1.78	3.56	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	41.43	3.39	1.51	0.75	2.26	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	52.97	2.18	2.18	1.45	0.73	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	35.11	1.25	1.25	1.25	0.00	3.76	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	49.75	3.79	2.31	0.82	1.32	0.33	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	50.50	1.36	4.09	1.36	1.36	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	42.82	2.71	3.77	2.26	2.11	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	47.15	2.14	0.00	0.00	1.07	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	46.67	2.46	2.46	1.13	0.38	0.94	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	33.68	2.67	2.94	2.41	0.27	1.07	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	34.14	1.95	4.88	1.95	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	39.14	1.66	2.82	0.83	0.00	0.83	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	24.01	1.20	1.20	4.80	1.20	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	42.48	0.00	7.08	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	40.65	3.09	2.06	1.37	1.03	0.51	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	0.00	8.39	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	48.06	3.88	2.43	0.49	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	41.36	3.42	3.42	2.28	1.52	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	27.86	0.00	1.21	2.42	2.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	42.18	0.00	2.85	1.14	1.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	42.11	2.57	3.42	1.07	1.28	0.43	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	27.87	4.13	2.84	1.03	1.29	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	47.86	2.35	2.35	1.88	0.00	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	42.12	3.54	1.29	1.29	0.96	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	22.83	2.14	0.71	0.71	0.71	2.85	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	35.10	2.34	2.34	0.00	1.17	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	49.68	3.01	2.11	1.20	0.30	0.30	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	30.89	2.38	4.75	3.56	0.00	2.38	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	44.24	3.05	3.05	1.02	1.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	53.23	1.53	2.29	2.55	1.02	2.80	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	37.49	3.18	2.54	0.64	0.64	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	44.02	3.02	1.73	1.29	0.86	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	40.64	3.60	2.96	1.48	0.85	0.42	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	28.13	4.06	3.48	2.03	1.16	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	46.29	0.00	0.94	1.89	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	44.25	1.53	3.22	1.02	1.36	0.68	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	41.69	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	31.69	4.23	6.34	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	45.88	3.22	3.86	1.29	1.50	0.43	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	30.08	5.41	1.80	1.80	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	26.24	0.00	2.19	1.46	4.37	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	45.75	3.45	2.76	1.15	1.61	0.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	45.91	2.55	0.00	2.55	2.55	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	44.49	5.59	3.81	2.03	1.27	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	50.78	2.06	4.54	1.24	1.24	0.21	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	28.46	2.14	3.37	0.92	0.92	0.61	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	50.67	3.82	3.35	2.39	1.43	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	45.68	5.32	4.21	0.89	1.33	0.67	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	33.57	1.53	3.05	4.58	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	47.08	2.77	3.32	1.66	0.00	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	46.07	2.91	3.71	1.59	1.06	0.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	36.34	3.27	2.91	0.36	1.09	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	44.46	2.58	0.86	0.61	0.49	0.86	0.00
Astrocyte - cerebellum, donor2	11580-120F5	31.66	1.88	0.51	0.34	0.34	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	29.57	0.21	0.42	0.21	0.00	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	81.92	1.05	1.39	0.70	1.39	0.00	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	83.80	4.04	1.13	2.26	0.97	0.81	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	79.35	1.94	1.04	2.39	0.60	0.60	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	79.94	2.98	0.34	1.03	0.23	0.11	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	82.06	4.13	0.25	1.00	0.75	0.25	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	74.76	3.87	0.80	0.34	0.00	0.46	0.00
Basophils, donor1	12241-129G9	20.92	7.32	12.03	0.00	0.52	0.00	0.00
Basophils, donor2	12242-129H1	24.89	10.10	18.76	0.36	1.08	0.00	0.72
Basophils, donor3	12243-129H2	37.04	6.76	14.70	0.00	0.73	0.15	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	111.25	89.48	17.68	2.16	0.22	0.65	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	21.03	5.94	3.66	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	86.08	35.87	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	27.62	10.67	5.02	1.26	1.26	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	25.99	4.57	1.66	0.42	0.62	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	40.30	5.30	2.99	0.46	0.92	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	93.93	23.57	11.16	2.16	0.90	2.34	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	42.56	14.12	0.41	0.41	0.10	0.82	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	49.61	12.34	0.23	0.93	0.00	1.63	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	35.18	5.12	0.96	0.00	0.32	0.64	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	27.05	6.76	17.47	0.00	2.82	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	35.08	6.31	13.36	0.37	0.93	0.19	0.37
CD14+ Monocytes, donor3	11381-118B4	36.22	5.71	13.39	0.44	1.76	0.22	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	116.61	5.38	26.32	1.42	2.26	1.13	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	92.49	7.96	29.57	1.52	1.90	1.14	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	136.76	9.20	35.83	0.66	2.30	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	111.88	26.74	73.86	3.18	3.47	2.17	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	97.16	31.08	63.97	0.60	3.32	1.21	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	107.79	25.35	71.07	1.66	2.37	0.95	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	115.00	32.31	56.25	2.34	3.52	1.17	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	136.90	49.41	65.97	3.59	2.21	1.38	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	146.03	38.43	65.70	2.23	2.23	0.99	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	101.42	18.21	36.42	2.15	2.94	0.78	1.17
CD14+ monocytes - treated with BCG, donor2	11870-125B7	81.19	21.01	34.90	1.42	3.56	0.53	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	102.50	23.50	43.31	0.22	2.83	1.31	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	93.42	10.07	25.75	1.64	2.11	0.23	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	108.25	12.67	35.91	1.06	1.06	1.58	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	114.26	7.77	31.06	0.00	3.33	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	109.48	30.79	63.81	4.31	2.97	1.19	1.34
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	120.93	48.29	78.22	2.20	3.99	1.20	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	139.91	48.51	107.64	1.67	4.16	2.08	1.25
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	127.89	25.17	65.20	2.52	1.60	0.92	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	117.85	35.51	65.83	1.58	2.71	2.04	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	79.87	18.33	54.12	0.87	1.75	1.31	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	58.91	11.30	43.58	1.88	3.23	1.34	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	69.26	17.62	42.22	0.87	1.92	1.05	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	75.75	11.36	45.03	2.10	3.37	1.68	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	194.73	29.94	63.75	2.57	4.59	2.57	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	215.94	47.91	71.86	3.17	4.23	2.82	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	208.83	38.17	84.67	2.19	6.14	1.32	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	86.14	14.47	29.29	2.62	1.22	1.57	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	90.32	16.73	24.90	0.37	1.12	1.49	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	94.63	21.99	44.62	1.08	2.37	1.29	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	156.42	31.94	56.10	2.46	5.32	0.41	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	148.58	37.55	52.62	1.16	2.78	0.93	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	145.23	27.61	69.37	2.09	4.87	0.70	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	56.67	18.09	80.21	1.53	3.49	1.09	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	94.48	27.72	76.69	1.62	2.31	1.15	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	78.41	17.55	58.92	1.52	2.17	1.30	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	48.59	6.23	28.50	0.31	1.87	1.25	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	60.78	6.64	22.01	1.05	0.70	0.52	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	66.67	8.25	37.24	1.56	2.23	0.89	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	69.15	20.67	77.06	2.30	3.83	1.02	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	94.19	26.57	91.56	1.32	2.42	1.10	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	80.64	23.16	98.75	1.26	3.58	1.89	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	34.55	0.00	2.03	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	35.93	1.36	1.36	0.00	0.68	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	48.67	3.11	1.04	1.04	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	81.02	2.13	1.60	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	47.17	1.07	0.54	1.07	0.54	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	38.61	1.40	3.51	0.70	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	40.79	3.14	0.78	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	46.14	2.64	1.32	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	18.90	5.75	1.64	0.00	0.00	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	7.25	6.53	0.00	0.00	0.73	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	6.06	5.05	0.50	0.50	0.50	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	181.42	2.02	8.49	2.02	4.04	0.81	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	161.39	2.00	7.99	0.80	2.40	1.20	1.20
CD34+ Progenitors, donor1	11545-120B6	12.05	6.02	6.02	0.00	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	24.16	9.55	8.43	0.56	1.69	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	50.73	6.76	0.75	0.38	0.38	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	44.19	8.34	1.35	0.90	0.23	0.23	0.23
CD4+ T Cells, donor1	11225-116C1	21.42	5.00	1.79	0.71	0.71	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	17.76	6.12	3.67	0.61	0.61	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	21.04	4.57	3.05	0.61	0.61	0.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	55.39	2.30	5.62	0.51	0.51	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	49.19	2.92	4.72	0.90	0.90	0.22	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	46.86	3.74	7.47	1.44	2.01	0.57	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	26.08	2.37	0.95	0.47	0.47	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	25.28	4.92	0.70	0.00	0.70	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	29.67	0.00	3.30	0.00	0.00	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	47.26	2.46	5.06	0.72	1.30	0.58	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	69.31	5.25	11.35	3.39	1.36	1.19	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	57.55	5.64	9.83	2.58	2.10	0.64	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	26.90	4.48	3.14	0.45	0.90	0.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	29.00	2.80	4.19	0.35	2.10	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	29.48	3.96	3.96	0.44	0.44	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	33.73	2.95	0.84	0.84	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	32.00	3.32	1.66	1.66	0.42	1.04	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	31.41	0.33	2.00	2.34	0.67	1.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	26.38	1.90	1.90	0.54	1.09	0.82	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	22.51	3.75	2.14	0.00	1.07	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	16.14	0.00	1.79	1.79	5.38	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	54.89	2.78	3.71	1.11	0.74	0.00	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	58.49	3.90	3.90	1.73	1.08	1.08	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	53.17	3.99	3.57	1.05	0.21	0.21	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	23.76	2.53	3.03	0.51	1.01	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	30.76	2.60	3.03	0.43	1.30	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	27.89	3.05	3.92	0.87	0.00	1.31	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	56.42	5.44	6.43	0.49	1.98	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	40.62	2.77	3.69	0.00	0.00	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	41.87	1.40	5.58	1.40	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	52.62	1.94	6.92	0.28	0.83	0.55	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	50.55	3.19	5.15	0.74	1.72	0.49	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	43.12	1.54	6.16	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	59.09	0.72	8.24	0.36	1.79	0.00	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	66.48	0.00	6.92	0.00	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	16.70	6.22	0.98	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	15.39	6.38	3.75	0.00	0.38	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	20.20	6.56	0.76	0.76	0.00	0.00	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	24.09	4.36	0.46	0.46	0.46	0.92	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	24.92	5.75	0.24	0.96	0.24	1.44	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	23.53	3.56	0.55	1.09	0.82	1.37	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	43.53	7.51	1.20	0.30	0.90	0.60	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	25.44	8.88	0.24	0.48	0.96	1.68	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	26.60	8.41	0.68	0.91	0.45	0.68	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	37.81	5.43	1.09	0.87	0.22	0.43	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	31.58	8.42	1.58	1.32	0.26	1.84	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	36.82	7.97	0.70	1.64	0.23	1.17	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	33.81	10.26	0.30	1.81	0.60	1.21	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	33.41	6.39	0.29	0.29	0.29	0.87	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	31.97	6.93	0.27	0.80	0.53	0.27	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	55.59	20.57	1.75	0.44	1.31	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	46.00	21.86	1.37	0.00	0.46	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	55.94	21.63	2.98	1.49	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	34.94	7.92	0.72	0.72	0.36	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	39.99	8.06	0.86	2.01	0.29	0.86	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	25.46	5.89	0.47	1.18	0.71	0.47	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	48.80	9.51	0.95	0.95	0.63	1.27	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	41.52	11.69	0.62	1.23	0.62	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	43.28	10.58	0.96	0.64	0.32	1.28	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	37.48	5.74	0.76	1.15	0.38	0.76	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	36.26	7.88	1.18	1.58	0.39	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	33.28	7.56	1.51	0.00	0.76	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	84.31	18.47	0.00	2.41	4.01	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	81.13	16.79	2.80	3.50	1.40	2.10	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	70.12	19.03	1.00	2.00	2.00	4.01	1.00
Cardiac Myocyte, donor1	11525-119I4	32.90	3.66	1.83	3.66	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	43.97	1.98	1.48	0.49	0.00	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	69.56	0.63	0.95	0.21	0.42	0.42	0.00
Chondrocyte - de diff, donor1	11261-116G1	63.44	6.24	5.20	3.12	0.35	1.04	2.08
Chondrocyte - de diff, donor2	11338-117F6	60.77	3.55	1.42	1.42	0.71	1.07	0.36
Chondrocyte - de diff, donor3	11410-118E6	53.82	2.84	2.96	2.05	0.46	0.91	0.57
Chondrocyte - re diff, donor2	11339-117F7	94.90	2.69	6.27	0.00	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	42.06	0.81	2.43	2.83	0.40	1.62	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	52.21	2.75	0.80	0.57	0.69	1.03	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	36.77	3.63	0.64	1.28	0.21	1.07	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	45.66	2.48	0.71	1.50	0.97	0.27	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	66.67	1.74	2.75	0.83	1.10	0.09	0.09
Corneal Epithelial Cells, donor1	11526-119I5	43.48	12.08	3.51	0.66	0.44	0.44	0.00
Corneal Epithelial Cells, donor2	11606-120I4	39.82	12.51	4.55	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	57.01	14.57	5.37	0.26	1.02	1.02	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	139.51	54.81	62.74	1.32	4.46	1.82	0.83
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	144.77	51.73	60.56	1.89	3.15	3.47	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	124.23	37.96	96.62	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	101.08	21.06	30.99	4.75	3.56	1.19	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	34.85	2.73	1.37	0.68	0.34	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	42.44	3.26	3.26	0.00	1.31	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	28.55	2.90	0.48	0.48	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	40.19	2.33	1.67	0.17	0.00	0.17	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	25.82	1.17	1.17	0.59	0.59	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	38.18	2.55	1.70	0.28	0.57	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	31.85	2.36	3.93	0.00	0.00	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	28.21	2.62	2.04	0.00	0.58	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	37.88	3.53	2.59	0.71	0.24	0.24	0.00
Endothelial Cells - Artery, donor3	11413-118E9	32.43	2.80	1.93	0.00	0.18	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	45.88	3.55	3.55	0.44	1.11	0.66	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	49.90	7.30	6.39	0.91	0.30	0.61	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	55.25	3.38	1.69	0.56	0.85	0.85	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	25.85	1.49	4.46	0.30	0.30	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	29.68	4.17	4.17	0.52	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	26.94	1.42	2.69	0.57	0.28	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	48.01	5.60	3.20	0.40	1.20	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	30.40	2.10	2.10	0.52	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	61.00	4.35	3.73	0.50	0.50	1.37	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	38.02	3.91	1.96	0.43	0.43	0.87	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	46.90	2.44	0.98	0.49	0.12	0.24	0.00
Endothelial Cells - Vein, donor1	11267-116G7	36.40	1.14	0.00	0.00	0.00	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	32.13	2.79	3.49	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	46.79	2.67	1.41	0.31	0.16	0.31	0.00
Eosinophils, donor1	12244-129H3	45.74	0.00	45.74	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	33.01	4.95	19.80	0.00	0.00	1.65	0.00
Eosinophils, donor3	12246-129H5	53.50	7.13	32.10	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	52.53	23.46	5.13	0.49	0.73	0.49	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	62.40	81.13	20.80	6.24	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	81.34	16.27	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	35.71	4.11	1.64	2.05	1.64	1.23	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	41.50	4.05	5.47	3.50	1.53	0.99	0.55
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	48.43	1.73	1.52	4.23	0.87	0.87	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	62.22	3.64	3.15	0.73	0.85	0.49	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	79.43	7.23	5.32	0.82	0.68	0.00	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	54.63	2.74	2.74	1.05	0.53	0.53	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	50.59	1.84	3.95	1.84	0.53	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	56.14	4.98	2.33	1.33	0.66	0.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	53.98	1.81	0.91	0.45	0.45	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	34.87	5.31	0.00	2.27	0.00	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	29.49	2.37	2.21	0.32	0.63	0.47	0.00
Fibroblast - Cardiac, donor4	11452-119A3	78.50	2.42	3.03	0.00	1.21	0.30	0.30
Fibroblast - Cardiac, donor5	11456-119A7	48.48	3.17	2.92	0.76	1.02	0.13	0.13
Fibroblast - Cardiac, donor6	11460-119B2	42.29	3.18	1.67	1.06	0.61	0.45	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	40.87	2.68	1.34	0.27	0.27	0.27	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	40.99	1.73	2.16	2.59	0.43	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	38.08	2.93	0.00	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	39.21	2.31	0.23	0.23	0.46	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	57.50	1.36	1.70	0.34	0.68	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	61.51	1.88	1.17	1.17	0.23	0.47	0.23
Fibroblast - Dermal, donor2	11346-117G5	46.22	0.94	1.42	0.00	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	61.89	2.54	4.11	2.54	0.73	0.48	0.00
Fibroblast - Dermal, donor4	11450-119A1	49.51	2.37	1.47	0.57	0.34	0.11	0.00
Fibroblast - Dermal, donor5	11454-119A5	51.64	2.27	1.57	1.40	1.05	0.52	0.17
Fibroblast - Dermal, donor6	11458-119A9	54.41	2.92	1.14	0.97	0.65	0.65	0.00
Fibroblast - Gingival, donor1	11237-116D4	61.64	3.12	2.08	0.83	1.67	1.04	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	55.02	1.83	3.93	1.31	0.26	0.52	0.00
Fibroblast - Gingival, donor2	11318-117D4	51.92	1.98	1.32	1.32	0.40	0.66	0.00
Fibroblast - Gingival, donor3	11394-118C8	77.45	2.90	2.90	0.77	0.58	0.39	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	49.87	0.00	2.08	0.00	0.00	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	48.10	1.06	0.88	0.88	0.70	1.41	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	47.55	1.40	1.40	1.40	0.62	0.31	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	45.44	1.76	1.89	1.08	0.95	0.00	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	48.70	2.12	0.71	0.00	0.35	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	43.87	1.75	2.19	1.75	0.88	0.44	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	42.00	2.45	1.09	1.36	0.41	0.14	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	45.30	2.41	1.86	0.77	0.33	0.00	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	46.81	0.59	2.79	1.61	0.59	0.15	0.00
Fibroblast - Lung, donor1	11270-116H1	19.03	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	40.29	0.00	0.00	7.46	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	38.83	0.84	1.06	0.84	1.27	0.21	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	44.98	3.33	0.00	0.00	1.67	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	34.97	1.40	0.00	0.00	1.40	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	17.07	1.40	0.28	0.56	0.28	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	71.04	4.06	1.22	0.41	0.41	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	19.97	0.00	0.00	0.00	0.00	7.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	47.65	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	55.67	1.75	0.58	1.16	0.78	0.39	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	58.85	1.52	0.76	1.06	0.30	0.46	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	90.88	3.37	5.51	0.92	0.31	0.00	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	52.28	1.53	0.76	0.00	0.76	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	54.54	1.08	1.08	0.81	1.08	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	52.07	1.97	2.32	0.35	1.04	0.35	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	67.09	2.54	2.76	1.11	0.66	0.66	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	48.56	2.24	1.22	0.00	0.20	0.61	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	36.08	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	38.35	1.98	1.19	0.40	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	51.20	1.39	0.60	1.59	0.20	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	52.93	0.53	1.07	0.53	0.53	0.53	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	54.40	1.58	0.99	0.99	0.39	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	33.70	1.81	0.90	1.20	0.60	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	45.99	1.08	1.19	0.54	0.54	0.54	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	45.30	0.51	0.76	0.51	0.00	0.51	0.00
Fibroblast - skin normal, donor1	11553-120C5	52.18	0.49	0.98	0.49	0.00	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	58.35	2.41	1.60	0.60	0.40	0.20	0.20
Fibroblast - skin normal, donor2	11561-120D4	62.09	2.11	2.81	0.70	0.80	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	47.75	1.51	0.00	0.30	0.91	0.60	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	48.63	1.57	0.83	0.91	0.50	0.50	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	49.58	1.71	1.88	0.34	0.34	1.03	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	51.24	0.33	0.66	1.31	0.66	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	54.33	1.49	2.45	0.64	0.53	0.32	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	49.25	1.35	1.52	0.67	0.34	0.00	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	48.77	0.31	0.94	4.08	0.00	1.73	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	398.88	22.16	22.16	22.16	0.00	22.16	44.32
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	74.95	20.05	115.91	6.97	6.97	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	96.56	16.47	21.32	0.87	2.25	0.17	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	93.69	17.18	13.79	1.82	1.30	1.30	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	91.73	8.69	12.01	0.51	1.53	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	49.76	7.66	1.53	3.06	3.06	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	68.91	12.76	0.64	2.55	0.64	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	96.13	9.13	1.43	2.00	1.43	1.71	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	109.20	5.52	3.86	4.14	1.10	0.83	1.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	71.01	4.34	2.28	1.37	1.60	1.37	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	77.67	8.92	1.59	2.18	2.18	0.59	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	111.29	6.61	3.17	2.11	0.79	1.85	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	61.97	4.57	1.96	2.28	2.61	1.96	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	72.08	4.86	2.21	3.54	0.88	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	80.27	6.50	0.42	0.85	0.42	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	82.75	7.63	0.99	1.48	1.35	0.62	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	61.25	5.91	1.07	1.34	1.07	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	104.44	8.80	1.12	2.11	1.61	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	110.19	6.92	1.38	1.25	1.11	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	66.07	9.15	1.02	0.61	1.63	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	71.42	5.93	2.51	2.05	0.46	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	95.29	5.73	1.49	1.62	1.37	1.25	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	95.30	8.52	2.40	0.87	1.09	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	67.66	6.21	1.77	0.59	0.89	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	76.46	2.86	1.75	1.27	1.11	0.79	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	77.30	8.71	1.79	1.12	0.22	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	61.50	4.84	0.81	1.61	0.60	1.01	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	70.40	4.58	1.53	1.02	0.85	0.68	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	93.02	17.73	3.01	0.71	0.80	0.18	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	70.55	5.10	1.35	0.42	0.62	0.00	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	71.21	5.29	0.85	0.17	0.85	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	66.72	3.32	1.33	1.22	0.66	0.33	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	76.87	13.56	2.25	0.58	1.33	0.00	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	83.51	13.48	2.25	0.61	0.61	0.41	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	48.28	3.71	1.65	0.62	0.41	0.21	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	65.14	3.11	0.58	1.50	0.46	0.46	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	55.53	3.00	1.83	1.83	1.17	0.17	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	50.48	1.76	0.22	0.44	0.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	69.86	3.20	0.86	0.86	0.61	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	54.30	4.86	0.97	1.30	0.32	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	55.80	2.89	0.96	0.64	0.64	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	62.54	3.41	0.38	1.42	0.38	0.47	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	53.15	4.11	1.11	0.63	0.16	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	38.92	2.43	1.82	0.30	0.00	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	64.19	3.66	1.46	1.05	0.31	0.42	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	46.33	3.95	1.54	0.66	0.88	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	50.50	2.52	0.28	1.12	0.56	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	58.05	3.43	1.20	0.37	0.93	0.56	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	44.12	1.87	1.60	0.80	0.53	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	57.53	5.05	2.30	2.60	0.77	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	61.40	3.24	1.55	1.04	0.78	0.26	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	43.37	2.98	0.54	1.63	0.54	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	47.75	2.77	0.92	0.92	0.92	0.18	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	46.49	3.51	1.32	2.19	0.22	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	53.55	0.99	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	46.96	2.77	1.45	1.98	0.40	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	48.22	1.82	2.22	1.41	0.40	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	85.14	3.05	1.52	0.25	0.51	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	83.21	11.74	0.80	1.19	0.40	1.19	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	91.68	7.55	1.08	1.85	2.16	0.92	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	96.77	8.80	1.23	0.82	1.84	0.61	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	72.29	12.83	0.31	2.19	0.94	1.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	64.42	8.48	1.98	1.41	0.28	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	65.03	9.22	0.92	2.31	1.84	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	89.09	7.42	4.95	7.42	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	73.88	10.83	1.93	1.93	1.93	1.55	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	85.04	8.02	1.60	6.42	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	60.86	6.96	1.74	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	78.11	8.14	2.28	1.63	0.65	1.63	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	72.48	4.53	1.65	5.77	0.41	1.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	46.65	3.33	0.00	3.33	0.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	71.59	5.31	2.24	1.68	1.40	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	71.58	4.90	2.61	1.63	0.33	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	63.75	1.68	2.52	7.55	0.00	2.52	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	70.93	4.45	1.27	2.54	0.64	0.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	59.78	3.74	0.68	1.70	1.70	1.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	75.17	0.00	0.00	4.18	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	72.73	5.15	2.29	1.15	0.57	0.57	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	54.76	1.48	1.18	2.07	0.30	0.59	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	59.30	5.08	0.00	1.69	5.08	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	63.37	5.80	1.66	2.49	0.83	2.07	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	66.28	4.60	1.84	2.30	0.46	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	68.49	5.27	10.54	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	58.43	2.69	0.77	0.77	1.92	0.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	47.59	5.22	1.30	2.93	0.33	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	60.20	2.68	0.00	4.01	2.01	2.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	65.88	2.70	1.93	3.47	0.39	0.77	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	85.58	5.48	2.05	2.40	0.68	1.71	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	69.57	4.97	0.00	4.97	0.00	2.48	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	72.66	3.30	0.94	2.83	0.47	1.89	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	74.23	1.81	0.60	2.41	1.81	1.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	68.67	2.54	2.54	1.53	0.00	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	58.63	2.39	1.60	2.79	1.20	0.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	55.26	3.45	0.99	2.47	0.00	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	63.74	4.72	2.36	4.72	0.00	3.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	63.01	2.33	2.33	2.92	0.00	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	81.63	4.39	1.76	3.95	1.32	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	57.64	0.00	0.85	3.39	0.85	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	53.72	1.79	1.19	2.98	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	46.10	0.49	0.97	4.37	0.49	1.46	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	45.65	0.00	2.28	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	31.19	0.00	1.66	0.00	0.00	1.25	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	29.24	0.00	2.25	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	46.31	0.95	6.34	0.63	0.95	0.63	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	44.28	2.92	4.60	1.25	1.25	1.25	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	56.28	4.99	2.20	1.51	0.46	0.81	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	78.49	3.54	1.69	1.52	0.51	0.17	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	66.66	5.92	1.82	0.91	0.68	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	66.35	4.81	1.64	1.31	0.55	0.33	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	67.70	9.24	2.15	0.21	0.21	0.43	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	63.29	4.31	1.51	1.29	0.65	0.65	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	57.91	4.23	1.25	1.49	0.37	0.37	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	63.99	6.18	1.37	0.69	0.69	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	67.60	4.16	1.28	0.64	0.64	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	36.38	1.12	2.24	0.56	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	32.46	1.73	0.87	0.00	1.30	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	42.30	10.58	7.93	7.93	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	44.44	0.71	2.82	0.00	0.35	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	21.07	0.00	0.73	0.00	0.00	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	50.18	1.05	0.35	2.45	0.17	0.70	0.00
Hepatocyte, donor1	11523-119I2	36.32	1.21	1.21	1.21	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	54.94	1.08	3.23	1.08	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	57.67	1.84	2.45	1.84	0.00	0.00	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	19.58	9.14	0.00	1.96	0.65	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	85.64	7.52	1.05	2.10	0.17	0.87	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	57.90	2.20	1.10	0.27	0.69	0.27	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	50.94	0.00	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	60.08	0.00	0.00	0.00	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	62.30	5.54	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	35.04	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	11.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	71.76	0.00	2.56	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	45.71	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	53.60	3.25	1.62	1.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	31.68	3.33	6.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	47.20	10.89	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	71.47	3.97	1.32	0.00	2.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	66.52	5.54	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	36.67	5.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	57.32	3.78	0.63	0.00	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	61.86	4.64	0.00	0.00	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	73.17	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	56.85	4.52	1.29	0.00	1.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	74.06	4.83	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	11.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	79.86	6.52	0.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	56.25	8.82	0.42	0.00	0.84	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	14.37	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	57.06	4.02	0.80	0.00	0.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	61.86	4.62	0.92	0.92	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	58.53	3.78	0.94	0.94	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	46.26	4.53	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	29.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	54.88	5.38	2.15	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	50.82	3.81	1.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	16.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	49.74	5.10	0.64	0.64	1.28	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	40.10	0.00	0.00	0.00	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	79.02	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	47.84	4.28	0.71	0.00	1.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	56.41	6.64	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	38.58	2.47	0.62	1.23	0.31	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	45.66	3.51	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	31.43	6.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	41.03	3.48	0.00	0.00	0.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	35.41	4.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	35.66	3.24	0.00	0.00	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	26.16	3.49	0.87	0.00	0.00	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	38.25	2.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	38.33	3.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	27.74	7.47	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	30.48	4.16	2.77	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	34.20	8.55	0.00	0.00	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	41.42	2.76	0.00	0.00	0.92	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	24.20	3.03	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	37.25	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	32.78	1.06	0.00	0.00	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	68.14	9.14	5.14	0.65	0.73	0.33	0.16
Keratinocyte - epidermal, donor2	11349-117G8	38.07	3.51	2.93	0.00	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	65.22	4.92	2.18	1.33	1.04	0.38	0.00
Keratinocyte - oral, donor1	11251-116E9	110.68	8.74	5.22	1.59	0.57	0.57	0.11
Keratocytes, donor1	11527-119I6	47.10	0.69	1.03	0.00	0.00	0.34	0.00
Keratocytes, donor2	11607-120I5	28.12	1.17	0.00	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	37.54	0.59	0.99	1.19	0.20	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	57.15	4.40	2.20	0.00	2.20	2.20	2.20
Lens Epithelial Cells, donor1	11529-119I8	35.60	1.08	3.24	1.08	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	81.31	0.69	0.46	0.58	0.12	0.23	0.00
Lens Epithelial Cells, donor3	11690-122I7	62.97	2.52	1.82	0.30	1.11	0.40	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	36.17	2.25	2.49	0.83	0.00	0.24	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	24.84	1.67	3.07	1.67	0.28	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	43.92	3.15	2.68	2.36	0.16	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	25.27	1.08	1.61	0.00	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	23.95	1.26	1.26	0.32	0.63	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	21.78	1.08	1.62	0.65	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	27.50	2.46	1.23	1.64	0.00	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	16.94	1.52	1.77	0.76	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	21.68	1.41	1.83	0.28	0.00	0.56	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	30.46	2.37	1.19	0.79	0.00	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	27.14	2.13	1.74	0.78	0.39	0.97	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	15.74	0.93	0.93	0.00	0.00	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	31.01	0.70	1.74	0.35	0.35	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	21.23	0.72	0.72	0.24	0.24	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	17.03	1.92	1.24	0.14	0.14	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	35.42	0.92	1.85	0.62	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	17.77	1.87	1.25	0.62	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	19.21	0.55	1.83	0.18	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	33.90	3.62	1.65	0.99	0.99	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	19.92	0.59	0.59	0.88	0.00	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	13.69	1.24	1.49	0.25	0.25	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	34.43	2.42	1.45	0.97	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	25.85	1.62	2.42	0.27	0.27	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	21.80	1.21	1.97	0.61	0.30	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	23.85	2.59	1.56	0.00	0.00	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	36.02	2.09	2.30	1.05	0.00	0.63	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	20.30	1.50	0.90	0.15	0.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	33.02	1.38	3.44	0.00	1.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	23.89	1.88	0.75	0.19	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	17.49	1.27	1.17	0.11	0.42	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	35.37	2.91	2.42	0.97	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	20.84	1.98	1.65	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	18.58	0.74	1.36	0.00	0.12	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	36.65	2.59	1.11	1.11	0.00	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	27.67	2.47	0.74	0.49	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	14.30	1.51	1.24	0.27	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	37.95	2.89	1.29	1.29	0.00	0.64	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	29.82	6.09	1.22	0.91	0.00	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	29.39	2.24	1.68	1.54	0.56	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	25.60	3.20	2.49	1.07	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	14.54	0.48	2.91	0.00	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	12.76	0.47	0.93	0.31	0.16	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	28.29	2.86	1.43	0.36	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	25.15	3.27	1.31	0.33	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	13.18	2.59	0.47	0.24	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	36.75	1.86	1.73	0.50	0.50	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	18.19	0.51	1.28	0.51	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	19.39	2.09	0.60	0.00	0.30	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	52.12	9.06	2.27	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	65.21	3.84	0.00	2.30	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	46.76	6.68	2.23	0.00	0.00	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	45.27	9.73	1.27	0.42	0.42	0.00	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	54.86	9.85	2.11	1.41	0.00	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	43.90	4.67	0.93	0.00	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	40.71	8.76	1.03	1.03	0.00	1.55	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	49.96	3.57	1.19	2.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	53.38	7.69	1.81	0.45	0.90	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	51.77	9.31	2.62	2.33	1.16	1.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	70.23	9.90	3.15	3.60	0.45	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	58.26	9.21	2.03	0.41	0.27	0.14	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	52.38	8.22	1.54	2.05	0.51	1.54	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	69.16	7.06	1.76	1.06	0.35	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	55.97	7.33	1.33	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	50.43	10.19	1.53	3.57	0.51	2.55	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	65.37	12.27	3.74	3.47	1.07	1.07	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	68.59	12.28	3.78	1.89	0.94	1.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	42.34	11.04	4.29	3.07	1.23	2.45	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	83.17	14.68	4.89	1.63	0.82	2.45	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	74.97	14.79	3.33	2.71	0.83	2.71	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	59.14	9.81	4.76	7.57	1.40	3.36	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	51.52	6.18	4.12	0.00	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	73.16	18.00	5.23	5.23	2.32	2.90	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	59.19	11.36	4.48	3.89	0.90	1.49	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	73.03	11.62	2.21	2.21	1.11	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	61.51	8.13	3.53	3.18	0.35	1.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	54.21	9.96	3.32	2.58	0.37	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	64.47	6.91	2.30	1.15	1.15	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	63.70	9.98	3.07	0.38	1.54	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	42.46	7.36	2.26	5.66	1.70	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	58.25	11.49	3.28	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	52.42	11.75	1.36	0.90	0.00	1.36	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	63.91	12.93	1.44	2.87	0.00	1.44	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	79.17	18.67	4.48	2.24	1.49	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	62.80	10.03	4.46	1.86	1.11	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	57.29	16.80	3.88	2.58	2.15	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	64.22	9.42	4.28	0.86	0.00	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	59.97	12.99	2.67	2.00	1.00	2.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	50.07	18.10	3.62	3.62	0.60	1.21	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	54.04	12.80	2.84	2.84	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	61.87	11.34	3.78	2.41	1.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	46.70	11.27	3.22	1.61	2.15	1.61	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	55.89	10.77	2.02	0.67	0.00	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	58.89	14.45	4.44	3.70	0.00	2.22	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	52.33	20.93	4.65	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	68.75	20.10	2.12	0.00	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	63.62	14.81	2.00	2.80	0.80	1.60	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	47.97	12.36	2.91	0.00	2.18	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	68.99	13.80	2.30	0.00	0.77	1.53	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	48.34	8.88	1.97	0.99	0.49	1.48	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	41.40	7.53	2.82	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	64.86	17.10	3.02	1.51	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	63.09	16.22	5.86	1.80	2.70	1.35	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	91.22	13.77	3.44	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	66.36	16.92	4.01	2.67	2.23	1.34	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	66.08	13.69	2.74	2.35	1.17	1.17	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	49.48	21.11	2.64	2.64	0.00	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	65.90	15.05	2.59	0.00	1.04	1.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	72.64	14.00	3.50	2.63	1.75	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	55.35	18.45	4.47	0.56	0.56	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	70.66	19.87	2.65	0.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	70.20	19.67	2.70	2.70	0.00	3.09	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	55.19	15.19	2.53	3.54	1.52	0.51	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	80.26	16.34	1.92	1.92	0.00	2.40	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	79.91	18.68	3.18	2.78	1.59	1.19	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	57.12	23.09	6.08	1.82	1.22	0.61	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	56.72	27.67	2.77	0.69	0.00	2.08	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	67.64	22.04	4.18	1.90	1.14	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	51.64	14.46	1.55	5.68	0.52	2.07	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	48.98	18.14	1.21	1.21	2.42	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	70.67	14.89	4.44	2.22	0.95	1.27	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	51.18	20.79	4.26	1.07	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	45.97	16.09	1.72	1.15	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	71.48	11.31	4.11	2.57	1.03	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	55.17	24.76	3.54	1.41	1.41	2.12	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	65.26	13.05	2.27	0.57	1.13	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	80.71	14.56	2.91	1.66	0.83	1.66	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	54.81	19.58	3.13	0.78	1.57	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	46.77	22.55	4.18	0.42	0.00	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	73.88	19.51	1.39	1.39	1.39	0.93	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	56.20	23.42	2.68	2.01	0.67	2.01	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	94.10	33.68	2.67	1.60	1.07	1.07	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	96.17	25.46	3.23	2.02	2.02	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	86.27	42.22	0.92	4.59	0.92	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	90.69	40.90	3.56	1.78	0.89	2.67	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	98.59	47.87	1.71	1.14	1.14	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	67.49	29.14	5.37	2.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	78.79	29.00	1.64	2.19	1.09	1.64	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	86.86	32.07	2.67	4.45	0.00	0.89	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	86.05	37.43	5.98	0.00	0.78	0.26	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	86.87	41.78	5.30	0.66	1.33	2.65	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	95.62	37.41	8.31	6.24	0.00	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	170.71	24.61	54.70	2.96	2.96	1.60	0.23
Macrophage - monocyte derived, donor2	11313-117C8	109.00	8.26	15.78	0.73	1.84	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	132.13	14.81	29.49	2.10	2.88	1.18	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	70.63	11.68	10.09	0.53	1.59	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	78.75	5.70	7.29	1.43	0.79	0.48	0.00
Mallassez-derived cells, donor3	11930-125I4	83.25	8.62	5.98	0.83	0.97	0.28	0.28
Mammary Epithelial Cell, donor1	11273-116H4	121.76	12.56	7.17	1.59	1.49	1.10	0.10
Mammary Epithelial Cell, donor2	11350-117G9	101.92	10.42	4.34	2.61	0.29	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	27.94	2.99	1.25	0.25	0.50	0.75	0.00
Mast cell - stimulated, donor1	11487-119E2	44.74	4.07	12.20	0.00	2.71	0.00	0.00
Mast cell, donor1	11563-120D6	52.77	3.89	4.43	0.97	0.32	0.11	0.11
Mast cell, donor2	11565-120D8	74.00	5.65	6.54	0.59	0.59	0.30	0.00
Mast cell, donor3	11566-120D9	83.07	4.73	8.33	1.13	1.13	0.23	0.23
Mast cell, donor4	11567-120E1	73.93	4.96	6.74	0.00	0.53	0.35	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	47.79	1.11	1.89	1.22	0.44	0.67	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	33.27	4.67	1.75	0.58	0.58	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	54.72	1.84	3.56	1.26	0.46	0.80	0.11
Mast cell, expanded, donor8	11941-126A6	43.68	3.68	5.86	0.50	0.84	0.33	0.00
Melanocyte - dark, donor1	11502-119F8	59.20	1.99	2.19	0.40	0.30	0.10	0.20
Melanocyte - dark, donor2	11582-120F7	45.68	2.08	1.38	0.35	0.35	1.38	0.00
Melanocyte - dark, donor3	11663-122F7	81.42	2.03	1.38	0.72	0.29	0.22	0.00
Melanocyte - light, donor1	11274-116H5	22.80	1.88	0.47	0.00	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	10.24	2.73	0.00	0.68	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	28.62	2.60	0.87	0.87	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	58.52	1.67	0.31	1.25	0.31	0.31	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	38.19	2.42	1.61	1.08	1.34	0.54	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	40.71	2.41	0.54	1.07	0.54	0.27	0.00
Meningeal Cells, donor1	11493-119E8	54.21	6.20	1.49	0.37	0.99	0.87	0.00
Meningeal Cells, donor2	11573-120E7	46.22	3.96	2.20	0.44	0.88	0.00	0.00
Meningeal Cells, donor3	11654-122E7	55.01	4.56	1.22	0.90	1.06	0.24	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	56.18	0.86	3.42	0.00	0.57	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	28.08	3.32	1.61	0.40	0.50	0.70	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	18.40	1.31	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	15.70	1.31	0.00	0.00	1.31	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	35.88	1.44	1.44	0.72	1.44	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	49.13	1.91	1.48	1.06	0.21	0.64	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	40.71	1.01	2.01	0.00	0.00	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	37.14	2.86	1.32	0.44	0.44	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	36.53	0.00	0.73	0.00	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	32.33	1.02	1.84	0.41	1.43	0.82	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	50.00	2.77	2.08	0.14	0.55	0.28	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	18.96	0.37	0.37	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	49.47	1.05	0.53	1.05	0.13	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	13.65	0.59	0.59	0.30	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	20.49	1.28	0.64	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	69.12	3.54	2.48	0.71	0.35	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	51.29	0.00	0.31	0.94	0.31	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	39.91	3.63	0.73	1.45	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	70.01	14.05	9.55	0.80	2.12	0.53	0.27
Mesothelial Cells, donor2	12156-128G5	57.55	9.51	10.01	0.50	1.50	1.00	0.00
Mesothelial Cells, donor3	11402-118D7	53.84	3.25	4.62	2.10	1.08	1.16	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	47.26	18.90	18.90	0.00	5.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	115.01	15.76	29.55	1.48	3.94	1.23	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	71.55	9.13	16.49	2.65	3.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	55.31	17.29	24.20	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	90.19	13.33	28.21	1.24	0.62	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	69.28	7.88	16.18	0.41	1.45	1.04	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	30.11	11.58	16.21	2.32	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	94.35	10.51	29.28	1.00	3.25	0.50	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	58.18	10.71	19.08	1.40	1.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	0.00	0.00	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	81.29	9.96	22.56	1.42	3.05	0.20	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	76.02	9.50	21.78	1.19	1.58	0.00	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	59.86	8.55	17.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	55.75	8.85	15.04	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	79.79	10.64	15.96	3.04	2.28	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	47.37	5.26	18.42	0.00	2.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	87.01	12.31	22.92	0.64	1.70	0.42	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	34.99	5.52	12.89	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	82.86	10.13	20.57	2.09	2.09	0.60	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	25.15	6.71	6.71	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	84.05	12.55	20.82	2.01	2.01	1.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	71.06	9.03	12.83	1.43	0.95	1.43	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	46.44	10.50	15.48	1.11	3.87	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	118.81	11.97	23.25	1.61	1.84	0.92	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	69.62	10.52	16.83	1.47	2.31	0.42	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	101.10	10.80	20.18	0.82	1.83	0.41	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	111.77	13.73	19.52	3.22	2.15	1.72	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	77.80	10.23	19.12	0.89	2.22	0.89	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	41.27	20.64	0.00	20.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	118.05	13.58	17.52	1.53	2.63	1.10	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	66.41	14.19	14.70	0.00	1.52	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	53.02	14.91	16.57	0.00	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	110.08	17.12	26.91	1.09	3.26	0.82	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	96.46	17.35	18.23	2.94	3.82	1.18	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	78.50	15.26	15.26	0.00	3.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	143.69	13.94	24.03	1.92	2.88	2.40	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	124.47	17.61	20.01	2.40	3.60	0.80	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	71.30	15.08	12.34	0.00	5.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	170.20	30.03	25.03	2.50	5.51	2.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	242.52	26.95	26.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	53.00	10.19	18.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	186.55	41.60	15.33	3.94	4.38	1.31	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	72.84	22.07	17.66	0.00	6.62	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	88.37	20.49	11.53	0.64	3.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	192.39	36.94	19.59	4.21	6.69	1.74	0.99
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	105.78	29.23	21.57	0.00	4.18	1.39	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	110.49	44.20	15.47	0.00	6.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	168.89	25.98	21.88	4.10	3.08	1.71	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	95.84	34.57	20.57	0.88	5.69	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	81.67	22.73	10.65	0.00	5.33	0.36	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	186.85	45.73	17.96	4.21	4.77	0.84	1.12
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	123.86	36.58	26.60	1.66	4.99	0.00	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	61.77	15.73	12.82	0.00	2.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	144.80	35.90	18.70	4.83	5.13	0.30	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	186.57	35.06	25.04	3.76	6.26	0.42	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	64.97	21.66	14.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	103.44	29.55	15.70	3.69	7.39	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	113.82	26.75	29.59	1.14	5.69	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	95.07	18.10	12.71	1.24	4.28	0.55	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	149.53	28.77	23.06	1.55	4.92	0.52	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	146.28	31.32	22.31	0.43	6.01	0.43	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	37.48	15.24	14.61	0.00	5.72	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	114.76	23.75	20.02	1.07	6.14	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	128.71	29.33	39.81	2.10	5.99	1.20	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	70.77	9.61	12.01	0.99	4.38	0.57	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	137.28	28.03	23.89	3.50	5.73	0.96	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	141.97	34.50	26.31	2.43	6.63	0.22	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	69.77	14.79	11.38	0.38	3.41	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	119.32	26.14	19.32	2.27	4.83	0.28	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	152.89	36.38	29.00	3.44	4.92	2.21	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	44.31	8.47	11.73	0.65	3.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	103.79	17.94	21.17	1.18	5.29	0.00	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	136.95	29.99	27.68	2.59	8.07	0.58	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	72.13	15.25	28.44	0.00	2.47	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	97.38	14.29	19.65	1.79	6.85	0.30	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	97.94	15.07	15.07	3.77	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	87.33	16.04	24.95	1.78	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	120.59	13.80	26.61	2.96	1.64	1.64	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	105.20	7.36	23.14	4.21	3.16	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	88.37	12.45	41.12	2.77	2.57	1.58	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	68.92	8.38	25.15	0.93	3.73	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	95.38	14.27	34.92	4.13	0.75	1.50	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	79.64	9.59	26.10	1.07	1.60	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	107.11	12.55	28.50	1.02	1.81	0.23	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	52.31	10.31	16.94	4.42	1.47	1.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	95.64	17.95	26.75	2.93	1.10	2.93	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	93.34	10.89	18.67	28.00	0.00	7.78	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	128.27	13.90	40.08	1.07	0.53	0.00	1.60
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	61.82	19.32	15.46	7.73	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	90.89	16.16	23.23	3.03	3.03	3.03	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	94.87	14.34	27.83	2.11	1.69	1.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	137.56	25.88	61.29	0.00	5.45	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	98.55	21.62	33.70	0.64	1.27	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	111.76	16.20	55.88	2.43	3.24	2.43	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	86.09	15.10	43.80	4.53	3.02	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	205.57	34.26	97.07	0.00	5.71	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	137.02	32.62	104.40	0.00	9.79	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	142.57	19.01	57.03	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	125.49	12.55	112.94	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	67.43	5.17	1.51	0.86	0.22	0.22	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	50.17	3.14	1.05	2.09	0.00	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	57.40	10.68	4.67	0.67	2.67	0.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	48.42	12.94	4.17	1.67	2.50	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	71.68	3.04	2.66	3.61	0.57	0.19	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	43.09	4.79	3.19	3.19	3.19	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	44.88	10.88	3.40	1.36	1.36	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	119.45	5.51	11.03	5.51	1.84	9.19	9.19
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	35.58	4.19	5.86	1.67	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	57.88	5.35	6.04	3.49	2.32	0.00	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	46.21	2.97	5.40	0.27	0.81	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	48.14	3.36	3.15	0.63	1.26	0.21	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	200.42	33.40	33.40	0.00	0.00	22.27	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	48.15	7.94	5.46	2.98	1.99	0.50	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	51.97	5.14	4.06	3.52	0.54	0.54	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	56.90	7.25	9.29	3.40	1.36	0.45	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	37.72	2.45	3.92	1.96	1.14	0.16	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	51.58	4.01	4.56	1.46	0.91	0.55	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	53.57	8.49	8.49	2.65	1.59	0.53	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	38.42	4.20	5.40	2.40	1.20	0.60	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	45.62	1.97	2.63	3.28	0.33	1.64	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	44.72	4.23	4.23	2.60	1.30	0.65	0.98
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	56.80	5.47	3.35	1.06	1.59	0.71	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	40.79	6.33	4.22	4.22	2.11	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	44.59	3.22	3.68	1.84	0.00	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	42.74	2.57	1.61	2.57	1.29	0.64	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	64.15	2.41	5.17	9.31	2.07	0.69	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	134.01	0.00	7.59	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	45.45	5.79	2.67	1.78	0.67	0.22	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	55.04	7.20	5.50	3.81	0.42	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	49.13	2.37	4.27	3.09	1.42	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	54.51	3.00	3.86	1.72	1.72	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	234.72	9.03	9.03	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	54.65	3.67	6.00	1.00	1.33	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	43.73	4.51	3.16	0.45	0.00	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	36.90	3.97	1.59	2.38	0.40	1.19	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	34.36	4.64	6.50	3.71	0.93	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	55.24	2.27	3.03	2.27	1.51	0.76	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	37.48	4.24	2.93	2.61	0.65	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	46.63	2.61	2.18	1.74	0.87	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	57.89	4.52	0.90	0.90	1.36	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	39.69	4.41	3.53	0.88	1.76	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	43.88	5.98	3.99	1.99	1.33	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	48.12	2.48	4.96	3.47	0.99	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	32.16	1.15	2.30	2.30	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	70.77	3.02	1.51	2.42	0.60	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	62.55	3.98	2.43	0.88	0.66	0.66	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	39.30	2.71	2.71	3.39	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	132.85	0.00	5.11	10.22	5.11	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	45.12	1.83	2.44	1.83	1.83	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	38.40	2.20	2.52	1.57	0.31	0.63	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	39.04	3.33	2.12	0.91	1.21	0.61	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	34.81	1.58	3.96	1.58	2.37	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	66.88	4.53	2.27	7.94	0.00	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	101.16	5.06	10.12	0.00	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	75.16	7.70	7.33	2.11	1.12	0.75	0.12
Myoblast, donor2	11322-117D8	93.78	12.66	6.14	3.84	2.69	1.92	0.38
Myoblast, donor3	11398-118D3	81.39	3.87	6.22	0.84	0.50	0.50	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	66.84	10.65	1.46	1.46	1.02	1.31	0.15
Natural Killer Cells, donor1	11230-116C6	22.14	6.46	2.77	0.31	0.62	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	14.17	6.03	1.81	0.00	0.30	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	17.30	5.89	2.58	0.37	0.55	0.00	0.00
Neural stem cells, donor1	11275-116H6	109.97	6.53	1.81	1.09	1.45	0.36	0.73
Neural stem cells, donor2	11352-117H2	144.42	1.93	0.00	1.93	1.93	0.00	0.00
Neurons, donor1	11494-119E9	91.03	3.41	2.28	3.41	4.55	0.00	0.00
Neurons, donor2	11574-120E8	98.63	2.64	1.54	1.98	1.32	0.66	0.00
Neurons, donor3	11655-122E8	82.22	1.64	2.47	3.29	2.47	1.64	1.64
Neutrophils, donor1	11233-116C9	50.11	6.50	31.55	2.78	1.86	1.86	0.93
Neutrophils, donor2	11314-117C9	40.58	5.80	43.48	2.90	2.90	8.70	0.00
Neutrophils, donor3	11390-118C4	94.68	6.11	74.52	0.61	3.67	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	57.11	1.42	2.37	0.24	0.83	0.12	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	26.05	0.98	1.63	0.00	0.33	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	41.51	0.40	1.20	0.60	0.80	0.40	0.00
Olfactory epithelial cells, donor1	11933-125I7	37.99	1.79	3.30	2.20	0.83	0.55	0.00
Olfactory epithelial cells, donor2	11934-125I8	42.99	1.30	2.46	2.89	0.87	2.46	0.14
Olfactory epithelial cells, donor3	11935-125I9	40.07	2.04	2.38	1.25	0.23	0.57	0.23
Olfactory epithelial cells, donor4	11936-126A1	50.65	1.56	3.02	1.95	0.78	0.49	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	101.11	3.61	1.20	0.60	1.81	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	31.27	1.49	1.70	0.85	0.64	0.00	0.21
Osteoblast - differentiated, donor2	11353-117H3	18.29	0.00	3.43	0.00	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	34.14	1.86	0.62	0.62	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	19.93	0.39	0.98	0.00	0.20	0.20	0.00
Osteoblast, donor2	11354-117H4	75.85	1.40	0.00	0.70	0.00	0.70	0.00
Osteoblast, donor3	11426-118G4	52.43	1.60	0.71	0.18	0.18	0.53	0.00
Pancreatic stromal cells, donor1	11249-116E7	60.23	2.02	2.78	1.18	0.51	0.59	0.08
Pericytes, donor1	11491-119E6	20.92	0.67	0.56	0.11	0.11	0.11	0.00
Pericytes, donor2	11571-120E5	24.90	1.36	0.91	0.68	0.45	0.45	0.00
Pericytes, donor3	11652-122E5	40.49	1.83	1.42	0.20	0.61	1.02	0.00
Perineurial Cells, donor1	11499-119F5	69.40	1.81	1.02	0.68	0.57	0.00	0.11
Perineurial Cells, donor2	11579-120F4	61.19	1.47	2.76	0.55	0.46	0.37	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	38.89	5.74	17.85	0.32	1.59	0.32	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	22.77	3.67	9.30	0.24	0.49	0.24	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	30.02	3.11	9.19	0.39	0.39	0.13	0.00
Placental Epithelial Cells, donor1	11278-116H9	44.48	1.43	0.96	0.48	0.24	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	29.94	2.22	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	26.11	0.39	0.79	0.39	0.20	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	36.08	1.27	1.90	2.85	0.95	0.63	0.00
Preadipocyte - breast, donor1	11467-119B9	37.89	2.44	2.63	2.25	0.56	0.19	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	48.82	1.70	2.87	0.52	0.65	1.04	0.00
Preadipocyte - breast, donor2	11328-117E5	49.31	2.25	3.38	2.48	0.68	1.13	0.00
Preadipocyte - omental, donor1	11468-119C1	47.31	2.34	3.09	0.96	0.32	0.43	0.11
Preadipocyte - omental, donor2	11329-117E6	52.81	2.62	6.11	1.75	1.31	1.31	0.87
Preadipocyte - omental, donor3	11403-118D8	70.48	1.72	2.86	2.01	1.86	0.86	0.00
Preadipocyte - perirenal, donor1	11469-119C2	37.40	0.00	0.98	0.98	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	25.80	0.92	1.23	0.31	0.00	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	61.62	2.12	2.48	1.42	0.71	0.18	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	56.88	1.87	1.19	0.34	0.85	0.00	0.17
Preadipocyte - visceral, donor1	11280-116I2	66.04	2.79	2.98	1.02	0.75	0.09	0.56
Preadipocyte - visceral, donor2	11357-117H7	57.06	0.00	3.22	2.76	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	46.29	1.57	2.61	0.52	0.94	0.21	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	97.45	10.41	1.66	1.51	0.60	0.15	0.45
Prostate Epithelial Cells, donor2	11331-117E8	66.22	7.31	6.91	0.41	1.22	0.41	0.14
Prostate Epithelial Cells, donor3	11404-118D9	140.85	21.86	7.23	3.25	1.10	2.27	0.24
Prostate Stromal Cells, donor1	11254-116F3	61.96	2.28	1.37	0.34	0.80	0.80	0.00
Prostate Stromal Cells, donor2	11332-117E9	65.09	2.87	1.08	0.90	0.00	0.90	0.36
Prostate Stromal Cells, donor3	11405-118E1	50.89	3.44	3.13	1.25	1.15	0.52	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	49.64	4.01	1.82	0.00	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	80.40	2.56	0.83	0.97	0.69	0.42	0.00
Renal Epithelial Cells, donor1	11517-119H5	35.00	0.51	0.51	0.00	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	45.52	4.27	2.13	0.00	0.00	1.42	0.00
Renal Epithelial Cells, donor3	11678-122H4	79.08	2.54	1.48	0.74	0.32	0.53	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	29.28	0.68	0.68	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	29.78	2.43	1.89	0.40	0.67	0.67	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	54.61	2.66	3.11	2.66	0.89	0.67	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	17.30	3.99	2.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	43.14	1.98	0.88	0.44	0.66	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	30.10	1.88	1.25	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	21.08	0.83	0.00	0.00	0.00	0.83	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	67.64	3.76	1.88	0.00	0.27	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	46.81	0.84	0.84	0.84	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	42.04	1.35	0.58	0.19	0.39	0.77	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	40.71	1.30	0.52	0.00	0.26	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	22.46	0.85	0.57	0.85	0.00	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	12.35	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	27.10	0.75	0.00	0.50	0.00	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	68.29	0.94	3.74	0.40	0.40	0.40	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	34.84	2.68	0.89	2.68	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	52.84	0.00	1.65	4.40	0.00	1.10	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	50.46	1.16	1.16	2.32	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	52.27	1.56	0.26	0.65	0.13	0.26	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	57.50	1.59	0.60	0.70	0.30	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	73.50	2.68	0.11	0.67	0.33	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	96.51	2.23	0.25	1.36	0.37	1.86	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	66.78	2.56	0.82	1.28	0.82	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	64.02	1.62	0.46	1.85	0.23	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	56.00	1.92	0.14	1.10	0.00	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	62.32	1.21	1.06	0.76	0.45	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	83.68	3.05	1.08	1.61	0.54	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	60.25	2.15	0.00	2.01	0.29	0.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	56.13	2.25	0.54	0.86	0.32	0.32	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	63.73	1.11	0.22	2.43	0.22	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	56.21	2.49	0.00	0.57	0.57	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	54.22	1.21	0.47	0.84	0.65	0.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	79.11	3.38	0.19	1.13	0.38	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	48.57	1.19	0.40	1.06	0.13	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	62.49	2.24	0.19	0.78	0.49	0.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	67.98	2.29	0.57	2.48	0.38	0.95	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	55.64	1.82	0.11	1.17	0.21	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	47.65	2.24	0.84	1.40	0.00	0.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	63.40	1.54	0.51	0.51	0.00	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	43.58	1.09	0.18	1.28	0.73	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	54.69	1.84	0.37	0.86	0.74	0.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	68.50	2.15	0.27	0.94	0.67	0.67	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	54.49	1.42	0.94	0.94	0.00	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	51.59	1.39	0.99	1.39	0.79	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	65.71	1.40	0.94	1.17	0.70	0.70	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	60.76	2.07	0.62	0.83	0.21	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	50.66	1.77	0.66	0.66	0.00	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	64.13	1.67	0.21	1.46	0.21	0.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	66.75	2.15	1.35	1.48	0.54	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	53.30	2.38	0.51	0.51	0.17	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	69.98	1.35	0.19	1.93	0.77	0.77	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	63.27	1.89	0.52	1.72	0.17	0.52	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	55.00	1.51	0.69	0.82	0.82	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	59.59	2.13	1.15	1.31	0.49	1.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	49.60	1.70	0.85	0.68	0.51	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	66.73	1.33	1.04	1.48	0.00	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	62.64	1.33	0.80	0.53	0.53	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	50.33	1.66	0.41	0.97	0.41	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	79.76	2.14	0.71	1.43	0.48	0.95	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	79.21	3.02	0.40	0.81	0.20	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	50.76	1.88	0.38	0.75	0.47	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	61.14	2.45	0.70	1.40	0.00	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	49.56	1.21	0.60	0.91	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	49.20	0.86	0.73	1.71	0.24	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	86.46	2.47	1.89	0.73	0.44	0.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	60.84	2.43	0.00	1.22	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	57.27	0.60	0.90	2.11	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	54.74	0.90	1.36	1.58	0.23	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	65.60	1.80	0.30	1.50	0.00	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	52.31	2.13	1.06	1.42	0.47	0.24	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	54.21	1.07	0.43	1.28	0.21	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	75.12	1.80	0.60	1.20	0.00	0.60	0.00
Schwann Cells, donor1	11498-119F4	20.69	1.13	0.75	0.38	0.38	0.19	0.00
Schwann Cells, donor2	11578-120F3	64.65	0.00	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	47.98	2.63	0.88	1.97	0.66	0.66	0.00
Sebocyte, donor1	11220-116B5	76.69	9.31	1.10	0.00	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	52.39	10.57	3.68	0.46	0.92	0.92	0.00
Sebocyte, donor3	11378-118B1	54.62	8.24	3.09	0.41	0.21	0.41	0.00
Sertoli Cells, donor1	11255-116F4	77.86	4.97	8.28	0.00	1.66	3.31	0.00
Sertoli Cells, donor2	11333-117F1	53.66	5.65	2.82	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	57.63	1.14	0.26	0.26	0.35	0.09	0.00
Skeletal Muscle Cells, donor2	11358-117H8	15.90	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	27.59	2.51	0.84	0.00	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	40.37	1.26	1.26	0.31	0.47	0.47	0.16
Skeletal Muscle Cells, donor5	11455-119A6	38.65	2.23	1.19	0.89	0.45	0.74	0.00
Skeletal Muscle Cells, donor6	11459-119B1	43.86	1.85	1.39	0.62	0.31	1.23	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	59.73	4.16	2.65	1.51	0.76	0.76	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	49.37	1.14	2.85	0.57	1.00	0.71	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	62.80	3.17	1.29	0.69	0.60	0.69	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	52.32	1.10	0.76	0.59	0.51	0.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	23.88	0.00	0.00	0.00	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	23.53	0.14	0.55	0.41	0.41	0.00	0.14
Skin - palm, donor1	10286-104F7	24.17	0.00	40.29	5.37	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	55.79	7.21	4.18	2.45	0.00	0.86	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	89.15	15.54	4.91	5.73	0.00	1.64	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	52.84	6.88	2.21	1.69	0.26	0.52	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	106.48	22.94	14.32	2.50	1.25	0.42	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	70.05	8.16	5.49	0.56	1.83	0.70	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	123.06	12.05	5.50	1.90	0.21	0.21	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	125.02	20.54	6.67	2.32	1.87	0.60	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	61.72	2.78	3.09	4.63	0.93	0.93	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	46.47	3.78	1.11	0.44	1.33	0.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	39.38	2.35	3.53	1.18	1.18	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	75.80	4.20	5.08	0.44	0.44	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	36.62	4.33	2.76	0.39	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	62.58	2.32	1.55	0.77	2.32	0.00	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	23.02	1.00	0.00	1.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	46.44	3.99	2.79	0.13	1.33	0.27	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	69.38	7.31	4.21	3.77	0.44	1.55	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	80.79	17.92	6.66	1.41	2.69	0.77	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	37.77	2.93	0.00	0.00	0.65	0.98	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	48.14	3.25	2.95	0.30	0.59	0.30	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	38.58	1.85	1.57	0.57	0.71	0.85	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	39.53	1.79	0.81	0.00	0.33	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	47.19	1.22	1.22	3.96	0.30	0.61	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	27.02	0.51	1.52	0.25	0.51	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	140.78	6.12	0.00	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	20.98	0.95	1.43	0.48	0.48	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	46.31	1.92	0.88	0.59	1.03	0.44	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	34.65	2.15	1.72	0.65	0.43	0.43	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	50.69	1.57	1.36	0.84	0.31	0.84	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	35.27	5.10	3.40	0.31	0.31	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	31.26	3.23	4.31	1.08	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	47.22	2.39	1.20	0.30	2.09	0.30	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	21.51	0.34	1.02	0.00	0.34	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	48.45	1.49	0.86	0.39	0.31	0.31	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	77.19	4.23	5.23	1.31	2.11	0.40	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	92.16	11.38	16.61	1.59	2.73	0.68	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	28.98	2.42	2.42	1.21	0.00	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	72.59	2.91	0.79	1.32	0.79	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	44.74	1.33	0.93	0.53	0.80	0.40	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	50.34	1.88	1.88	1.38	0.63	0.88	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	49.21	5.58	6.34	0.76	1.01	0.76	1.27
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	83.98	8.44	8.44	1.06	1.81	0.45	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	30.01	0.00	1.50	0.75	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	301.09	3.88	7.75	0.00	6.46	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	39.07	1.40	1.40	0.00	0.47	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	52.51	5.55	3.03	0.00	0.00	1.01	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	44.19	7.52	6.27	0.94	0.94	0.31	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	35.69	2.06	1.18	0.88	0.88	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	75.14	3.42	2.83	0.17	1.25	0.00	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	40.18	0.47	2.80	0.47	1.40	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	33.25	2.59	1.30	0.43	0.72	0.14	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	45.89	1.78	2.29	1.02	0.76	0.51	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	19.93	1.32	0.38	0.38	0.38	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	65.82	2.52	0.84	0.70	0.28	0.28	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	74.15	1.51	0.84	0.67	0.34	0.25	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	18.57	0.48	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	40.86	1.96	0.73	0.00	0.24	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	39.55	1.33	2.21	0.88	1.10	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	26.04	1.17	0.88	0.29	1.17	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	41.98	2.14	1.75	1.17	0.78	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	44.16	2.38	2.12	5.02	0.79	0.00	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	47.98	2.98	3.35	4.09	1.49	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	57.85	9.34	6.11	3.59	1.80	1.08	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	57.06	4.54	3.41	2.56	0.00	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	41.75	2.36	1.18	0.39	0.79	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	49.52	2.29	3.81	4.06	0.51	0.76	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	44.72	0.40	2.80	2.80	1.60	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	49.74	4.18	1.67	4.60	0.84	1.25	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	39.42	1.83	1.38	2.75	0.92	0.92	0.00
Synoviocyte, donor1	11291-117A4	48.81	1.51	3.03	2.86	1.35	0.34	0.17
Synoviocyte, donor2	11368-117I9	64.54	4.86	6.54	2.35	0.67	0.84	1.17
Synoviocyte, donor3	11440-118H9	48.48	0.67	4.24	3.13	1.12	0.45	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	44.31	2.50	0.71	0.00	0.00	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	27.75	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	22.92	0.69	0.69	0.23	0.23	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	66.88	6.45	2.44	0.93	0.79	0.43	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	35.18	5.03	1.55	0.00	0.39	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	21.19	3.44	1.72	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	69.02	0.74	4.92	1.11	0.74	0.62	0.12
Urethra, donor2	10319-105A4	57.55	5.40	7.19	8.99	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	57.65	9.30	1.86	0.53	1.06	0.80	0.00
Urothelial Cells, donor2	11600-120H7	48.87	14.42	1.60	0.80	0.80	1.60	0.00
Urothelial Cells, donor3	11681-122H7	48.59	17.88	5.27	0.92	0.69	0.69	0.00
Urothelial cells, donor0	11216-116B1	82.03	7.80	8.92	0.00	0.45	0.45	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	88.98	3.56	56.06	1.78	2.67	0.89	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	85.78	5.72	64.33	2.86	1.43	2.86	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	64.34	2.74	41.76	1.37	2.05	0.00	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	58.88	2.07	22.73	1.03	0.00	0.34	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	61.01	2.32	30.21	1.16	1.16	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	76.01	4.16	53.10	2.08	2.08	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	82.60	6.42	67.00	1.84	2.75	0.00	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	50.21	4.56	25.56	0.00	1.83	1.83	0.00
Wilms' tumor cell line:G-401	10809-111A8	69.08	9.13	1.85	2.10	1.36	0.74	0.25
Wilms' tumor cell line:HFWT	10597-108E3	30.80	16.72	0.88	0.88	0.88	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	93.57	13.69	1.96	1.96	0.56	1.96	0.00
achilles tendon, donor2	10292-104G4	51.66	10.33	14.47	4.13	4.13	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	43.60	7.90	1.02	2.29	0.51	1.02	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	58.74	7.20	0.70	0.46	0.00	1.39	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	62.32	12.23	0.83	0.95	0.47	0.83	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	51.97	4.90	0.00	3.27	0.82	2.72	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	64.09	5.62	0.84	3.37	0.00	3.37	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	48.01	9.31	2.75	0.63	0.85	0.42	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	114.87	18.78	5.17	2.99	1.36	0.54	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	40.10	12.78	1.32	2.64	0.88	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	49.00	7.35	1.23	1.63	0.41	1.63	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	37.66	8.15	1.16	2.72	0.00	0.78	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	58.14	4.97	1.10	1.29	0.18	1.66	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	101.41	15.60	3.90	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	72.50	7.90	3.25	1.39	0.46	0.46	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	65.24	3.88	0.26	2.59	0.26	2.33	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	43.84	1.75	0.58	1.46	0.29	2.92	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	58.56	8.83	1.86	0.46	0.46	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	44.83	8.64	2.06	2.06	1.65	0.82	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	55.86	4.30	1.53	2.76	0.61	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	76.81	2.56	1.28	0.85	0.43	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	80.68	3.64	1.21	0.61	0.30	0.91	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	80.15	2.17	0.48	0.72	0.24	0.96	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	78.40	8.24	1.34	2.23	0.22	0.00	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	32.35	2.33	1.00	0.33	0.33	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	59.46	7.43	0.00	0.00	0.00	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	81.36	3.77	2.26	1.88	0.38	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	48.41	13.08	1.74	1.31	0.44	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	48.74	3.75	7.50	0.00	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	61.70	2.35	0.47	1.18	0.24	0.47	0.00
adipose tissue, adult, pool1	10010-101C1	63.91	1.40	4.65	0.31	0.31	0.62	0.16
adipose, donor1	10184-103D4	127.25	2.35	2.93	3.52	1.76	2.35	1.17
adipose, donor2	10185-103D5	45.42	2.03	1.22	2.43	0.00	0.41	0.41
adipose, donor3	10186-103D6	73.25	2.18	2.72	2.72	1.63	0.54	0.00
adipose, donor4	10187-103D7	197.62	6.93	4.33	1.73	4.33	1.73	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	57.92	2.05	1.26	0.79	0.47	0.00	0.16
adrenal gland, adult, pool1	10081-102A9	65.48	3.64	3.64	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	68.30	4.94	1.07	0.93	0.53	0.93	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	68.24	8.93	1.07	1.79	1.07	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	100.39	0.93	4.41	1.39	0.70	1.16	0.00
amniotic membrane cells, donor2	12236-129G4	87.91	1.69	2.37	1.69	0.34	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	68.94	0.88	2.95	1.18	0.29	1.18	0.00
amygdala - adult, donor10196	10167-103B5	73.52	0.00	2.37	3.56	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	94.29	1.22	3.04	5.27	0.81	0.41	0.00
amygdala, newborn, donor10223	10360-105E9	56.48	1.94	3.87	3.55	0.32	0.00	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	69.65	5.73	1.02	0.89	0.25	1.78	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	35.52	3.75	0.44	2.21	0.00	0.66	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	54.11	14.36	2.34	2.00	0.00	1.00	0.00
aorta, adult, pool1	10052-101G7	55.31	0.59	2.35	1.37	0.39	0.39	0.20
appendix, adult	10189-103D9	64.04	3.10	8.15	0.39	0.00	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	40.24	4.13	1.03	0.34	0.00	1.03	0.00
artery, adult	10190-103E1	67.93	5.43	6.79	6.79	0.00	1.36	1.36
astrocytoma cell line:TM-31	10425-106D2	96.05	11.59	4.93	2.32	4.06	2.46	0.29
b cell line:RPMI1788	10427-106D4	42.68	5.35	0.59	1.04	0.15	0.45	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	35.79	5.55	5.55	1.39	1.11	1.39	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	49.52	9.23	1.69	0.00	0.60	0.69	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	127.37	24.27	5.86	1.67	1.51	1.17	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	30.20	3.36	2.80	2.80	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	66.71	1.30	2.50	1.74	0.33	0.43	0.11
blood, adult, pool1	10053-101G8	59.79	4.43	19.93	2.21	2.21	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	13.70	3.43	3.43	0.00	0.86	0.86	0.00
bone marrow, adult	10192-103E3	39.81	4.72	4.72	4.05	0.67	0.00	0.00
brain, adult, donor1	10084-102B3	58.43	0.00	1.03	0.00	1.03	1.03	0.00
brain, adult, pool1	10012-101C3	83.52	0.67	2.67	1.56	1.56	0.78	0.11
brain, fetal, pool1	10085-102B4	90.83	2.67	8.01	8.01	2.67	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	65.08	9.58	5.29	1.32	1.32	1.98	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	63.41	5.87	1.50	0.37	1.37	1.12	0.37
breast, adult, donor1	10080-102A8	61.24	1.89	3.16	1.26	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	37.98	2.16	1.27	0.89	0.25	0.64	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	49.48	2.47	2.16	0.93	0.00	1.55	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	89.79	6.45	0.69	5.76	0.69	1.61	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	53.99	3.87	0.97	2.66	0.48	1.45	0.00
carcinoid cell line:NCI-H1770	10703-109H1	55.48	2.35	0.00	3.29	0.00	1.41	0.00
carcinoid cell line:NCI-H727	10735-110B6	59.39	3.94	1.09	0.33	0.33	0.44	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	52.29	1.90	0.63	1.90	0.00	1.58	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	52.70	1.86	1.06	3.19	0.53	1.60	0.00
caudate nucleus - adult, donor10196	10177-103C6	72.53	0.00	2.30	3.45	4.61	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	94.37	0.84	2.84	2.68	0.84	0.33	0.00
caudate nucleus, adult, donor10258	10379-105H1	49.67	0.76	2.29	1.53	2.29	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	62.99	2.20	2.20	2.20	0.73	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	93.22	0.00	0.00	2.91	5.83	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	119.14	0.64	2.99	1.92	0.43	0.21	0.00
cerebellum, adult, pool1	10083-102B2	54.16	1.03	1.03	1.38	0.69	0.69	0.34
cerebellum, newborn, donor10223	10357-105E6	68.91	5.81	4.15	4.98	2.49	0.00	0.00
cerebral meninges, adult	10188-103D8	73.88	0.25	2.02	1.26	1.76	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	43.12	6.58	13.89	6.58	0.73	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	98.06	6.04	1.15	1.15	0.43	0.29	0.00
cervical cancer cell line:ME-180	10553-107I4	150.30	32.15	38.45	2.49	2.32	1.33	0.00
cervix, adult, pool1	10013-101C4	82.31	9.34	20.37	1.05	0.63	0.31	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	66.88	5.02	0.98	2.79	0.70	0.84	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	27.43	3.92	0.00	0.00	3.92	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	76.93	7.71	2.11	1.49	0.37	1.37	0.00
choriocarcinoma cell line:SCH	10785-110H2	89.70	5.67	0.86	2.46	1.36	0.74	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	69.26	7.83	1.19	0.00	1.90	0.71	0.00
chorionic membrane cells, donor1	12238-129G6	74.93	2.56	0.85	0.85	0.28	1.42	0.00
chorionic membrane cells, donor2	12239-129G7	70.10	1.69	2.78	0.60	0.30	0.50	0.00
chorionic membrane cells, donor3	12240-129G8	69.24	1.10	3.30	3.30	0.55	2.75	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	22.22	27.26	3.03	0.00	0.00	5.05	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	48.60	4.99	0.96	0.77	0.00	0.58	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	43.93	4.86	2.11	1.69	0.84	0.63	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	97.84	4.88	0.77	1.80	0.77	0.51	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	110.54	4.84	0.73	0.97	0.48	0.48	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	112.60	5.29	2.04	1.43	0.61	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	62.72	7.36	1.18	3.53	1.47	2.65	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	62.29	4.17	0.52	0.00	0.26	0.52	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	41.14	3.66	0.46	3.43	1.14	1.83	0.23
clear cell carcinoma cell line:TEN	10636-108I6	38.17	5.03	0.69	0.87	0.00	2.08	0.00
colon carcinoma cell line:CACO-2	10513-107D9	71.39	11.35	1.46	1.46	1.10	1.46	0.00
colon carcinoma cell line:COLO-320	10420-106C6	76.78	5.70	0.38	1.14	0.38	1.52	0.00
colon, adult, donor1	10082-102B1	59.50	0.00	9.52	5.95	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	72.97	1.29	4.35	0.94	0.82	0.12	0.12
colon, fetal, donor1	10070-101I7	45.73	0.00	3.09	4.94	0.00	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	142.09	41.25	4.58	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	28.05	15.30	0.42	0.85	1.27	2.12	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	43.92	14.79	0.91	1.06	0.60	0.60	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	36.38	9.31	1.97	0.28	0.71	0.85	0.14
corpus callosum, adult, pool1	10042-101F6	130.46	0.88	3.10	1.00	1.88	0.33	0.00
cruciate ligament, donor2	10295-104G7	40.52	4.05	17.02	0.00	1.62	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	61.80	0.80	1.61	4.82	0.00	1.61	0.80
diencephalon, adult	10193-103E4	72.96	0.72	1.44	1.68	3.12	0.48	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	35.36	8.04	0.69	1.84	0.69	0.92	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	53.08	4.87	1.03	0.00	1.54	0.51	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	71.74	5.30	1.93	1.69	0.72	0.24	0.00
ductus deferens, adult	10196-103E7	52.33	0.00	1.50	2.99	0.50	0.50	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	59.05	1.44	0.00	1.44	1.44	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	64.00	1.47	1.47	3.68	0.74	3.68	0.74
dura mater, adult, donor1	10041-101F5	49.88	2.48	3.47	0.50	0.33	0.00	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	73.28	16.21	2.00	0.89	1.78	0.67	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	50.15	3.01	0.43	1.29	0.43	0.57	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	26.51	1.85	0.00	0.62	1.85	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	24.52	8.48	1.82	0.61	0.30	1.82	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	45.39	8.64	2.16	1.23	0.62	0.93	0.00
embryonic pancreas cell line:2C6	10603-108E9	66.99	9.19	3.94	0.00	1.31	3.94	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	81.45	6.03	1.68	0.67	0.00	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	83.01	7.43	1.63	4.35	0.72	4.35	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	40.85	3.86	1.61	2.73	0.32	1.29	0.16
epidermoid carcinoma cell line:A431	10426-106D3	59.25	7.67	3.78	0.33	0.22	0.78	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	69.62	12.76	1.10	0.55	0.44	0.88	0.00
epididymis, adult	10197-103E8	49.19	0.42	1.67	0.84	1.05	0.00	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	66.17	2.48	0.89	3.55	0.35	1.42	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	35.00	5.51	1.18	1.57	1.18	0.79	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	90.56	10.09	2.10	1.18	0.66	0.52	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	105.41	13.88	3.25	1.87	0.59	0.39	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	99.48	8.96	2.69	1.46	0.67	0.56	0.00
esophagus, adult, pool1	10015-101C6	175.30	52.88	80.06	2.02	2.02	1.38	0.96
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	93.43	3.38	1.25	0.88	0.13	0.88	0.00
eye - muscle inferior rectus, donor1	10272-104E2	38.63	0.00	2.41	14.49	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	25.25	6.31	8.42	4.21	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	34.23	1.49	0.00	0.00	0.00	0.00	1.49
eye - muscle superior, donor2	10297-104G9	47.01	2.29	4.59	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	40.81	4.37	17.49	1.46	5.83	0.00	0.00
eye, fetal, donor1	10054-101G9	62.54	1.27	1.53	2.54	0.76	0.00	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	39.75	4.36	1.15	1.67	0.13	0.64	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	57.46	2.61	1.66	3.32	0.24	0.95	0.00
frontal lobe, adult, pool1	10040-101F4	96.17	0.94	3.38	0.75	1.50	0.38	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	187.96	19.82	9.31	11.11	1.50	6.31	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	72.05	6.95	0.64	0.27	0.27	0.55	0.00
gall bladder, adult	10198-103E9	67.12	2.41	4.35	1.93	1.21	0.24	0.00
gamma delta positive T cells, donor1	11937-126A2	35.97	4.29	3.76	1.07	0.54	1.61	0.00
gamma delta positive T cells, donor2	11938-126A3	32.87	4.48	14.57	0.37	0.37	1.12	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	29.57	1.90	0.63	0.84	0.63	2.11	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	46.81	3.87	0.97	2.32	0.58	0.77	0.19
gastric cancer cell line:AZ521	10549-107H9	65.91	7.71	1.97	0.98	1.15	0.66	0.16
gastric cancer cell line:GSS	10560-108A2	41.19	1.83	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	45.69	7.54	1.14	1.83	0.91	1.60	0.00
giant cell carcinoma cell line:LU65	10487-107B1	54.73	4.36	0.46	1.84	0.34	0.69	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	60.46	3.50	1.26	0.70	0.42	1.12	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	77.32	8.98	2.49	2.99	0.50	0.75	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	45.81	3.06	1.37	0.53	0.42	0.53	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	47.05	3.65	0.98	0.98	0.42	0.56	0.00
glioblastoma cell line:T98G	10485-107A8	46.03	7.28	1.66	1.21	0.11	1.21	0.11
glioma cell line:GI-1	10413-106B8	32.22	2.93	0.29	0.59	0.00	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	72.16	0.73	5.83	6.56	3.64	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	140.11	2.20	3.66	5.86	1.46	0.98	0.00
globus pallidus, adult, donor10258	10367-105F7	68.46	1.37	1.37	0.00	0.00	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	66.08	1.60	2.66	0.00	2.13	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	122.36	51.39	4.89	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	10.93	0.00	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	19.52	0.96	1.28	1.28	0.96	0.96	0.00
hIPS +CCl2, biol_rep1	14383-156B9	103.76	15.15	3.21	1.84	1.38	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	100.60	7.32	0.00	1.37	0.46	0.46	0.46
hIPS +CCl2, biol_rep3	14385-156C2	95.33	14.17	1.29	2.58	1.29	2.58	0.00
hIPS, biol_rep1	14380-156B6	110.67	11.50	2.87	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	82.99	11.66	0.00	2.06	0.69	0.69	0.00
hIPS, biol_rep3	14382-156B8	69.52	2.21	6.62	5.52	3.31	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	29.88	3.45	1.72	2.30	0.00	0.29	0.00
heart - mitral valve, adult	10205-103F7	44.85	0.90	3.29	0.30	0.00	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	49.68	1.31	1.31	1.31	0.52	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	86.59	1.67	0.83	2.50	1.67	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	52.03	2.45	1.02	4.08	1.02	0.82	0.00
heart, adult, diseased, donor1	10051-101G6	38.32	0.85	1.70	1.28	0.43	1.70	0.00
heart, adult, pool1	10016-101C7	68.76	0.69	2.07	0.69	0.23	0.23	0.00
heart, fetal, pool1	10046-101G1	81.32	1.03	1.13	0.51	0.21	0.21	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	39.49	2.16	2.47	2.16	0.62	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	38.05	7.14	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	112.71	5.08	1.10	1.10	0.22	1.22	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	123.44	6.92	0.61	0.85	1.21	0.49	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	123.99	5.86	0.51	0.81	0.20	0.91	0.00
hepatoma cell line:Li-7	10484-107A7	66.28	8.12	1.33	0.78	0.22	1.00	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	64.02	8.04	0.40	0.60	0.30	0.30	0.10
hippocampus - adult, donor10196	10169-103B7	86.12	1.89	4.73	4.73	1.89	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	102.87	1.02	3.67	6.94	1.43	1.22	0.20
hippocampus, adult, donor10258	10374-105G5	72.70	1.49	1.49	2.99	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	49.35	2.11	1.76	0.70	2.11	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	89.72	12.82	0.00	3.66	1.22	1.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	65.78	7.27	1.37	1.57	0.98	0.20	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	61.44	11.43	0.76	0.76	1.27	0.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	88.53	7.33	0.56	3.38	0.56	0.56	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	82.37	2.32	2.32	7.23	1.55	6.97	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	88.83	5.31	3.42	1.90	0.76	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	49.92	4.96	2.04	1.46	0.58	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	66.57	5.17	1.94	2.37	0.43	0.65	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	62.56	7.09	1.25	2.09	2.09	0.83	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	47.60	4.97	0.71	0.95	1.18	1.18	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	47.73	3.21	1.61	1.61	0.80	0.80	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	41.07	2.69	0.00	1.35	0.67	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	63.69	10.64	1.25	1.41	1.72	0.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	60.43	6.88	0.98	2.95	1.47	3.93	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	68.07	8.73	0.87	6.11	2.62	1.75	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	90.87	2.86	2.48	1.34	0.76	0.38	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	81.55	5.67	0.87	1.74	1.31	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	89.46	3.50	2.00	4.00	0.00	0.50	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	49.17	2.83	0.94	1.13	0.57	0.75	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	55.48	2.73	1.82	2.73	0.45	0.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	54.50	2.19	1.88	1.25	1.57	1.88	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	52.75	2.61	1.96	2.61	1.14	0.49	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	53.13	2.90	2.61	2.03	1.45	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	48.43	2.99	0.30	1.20	0.90	0.90	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	70.39	13.86	1.85	2.77	2.22	1.29	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	69.89	8.56	1.14	1.71	2.57	0.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	94.73	12.25	2.45	0.82	0.00	3.27	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	69.71	6.34	2.82	1.41	0.70	1.76	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	64.62	2.53	1.27	1.27	0.32	0.95	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	68.09	4.84	1.21	1.21	0.61	0.61	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	58.43	7.24	2.59	1.03	0.52	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	47.16	1.33	0.00	1.33	1.33	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	35.40	2.05	1.03	0.51	0.51	0.26	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	43.20	3.58	1.28	1.53	0.77	0.26	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	48.46	3.79	0.76	0.00	0.00	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	38.31	2.35	0.67	0.67	1.01	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	69.07	9.90	2.90	1.21	0.97	1.21	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	60.61	11.14	1.34	1.78	1.34	0.89	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	62.44	11.22	0.98	1.46	1.46	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	83.13	6.11	2.44	0.92	0.00	0.31	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	286.29	0.00	0.00	16.27	0.00	16.27	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	103.58	2.98	4.30	2.98	0.99	1.99	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	65.13	4.38	1.09	1.64	0.00	0.55	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	53.20	4.70	1.09	1.45	1.81	0.72	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	51.96	2.85	1.78	2.14	0.36	0.00	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	45.35	3.58	0.00	0.00	1.19	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	75.43	4.20	1.76	1.49	1.22	0.95	0.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	33.67	1.35	1.08	1.89	0.81	0.81	0.27
immature langerhans cells, donor1	11904-125F5	66.35	21.07	45.77	0.97	6.05	1.21	0.24
immature langerhans cells, donor2	11905-125F6	95.06	11.09	47.53	1.58	3.17	0.79	0.79
insula, adult, pool1	10039-101F3	94.63	0.66	2.08	0.66	0.85	0.28	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	90.07	12.03	14.63	1.95	0.65	0.33	0.00
kidney, adult, pool1	10017-101C8	78.00	1.50	5.11	0.80	1.50	0.10	0.00
kidney, fetal, pool1	10045-101F9	66.28	1.06	2.26	0.42	0.42	0.14	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	38.20	7.39	1.14	0.43	0.57	0.71	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	76.17	35.67	2.90	2.49	0.97	1.94	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	54.32	8.07	0.18	0.92	0.73	0.37	0.00
left atrium, adult, donor1	10079-102A7	37.05	0.54	3.81	1.09	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	32.87	1.01	2.53	1.01	0.51	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	80.71	9.03	1.09	0.82	0.00	0.55	0.00
leiomyoma cell line:10964C	10569-108B2	41.67	2.51	4.31	1.08	0.72	1.08	0.36
leiomyoma cell line:15242A	10570-108B3	44.57	3.26	1.63	2.17	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	50.26	2.67	1.94	1.70	0.49	1.21	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	12.70	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	26.14	4.18	0.00	0.00	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	56.90	7.56	1.65	1.06	0.83	0.83	0.12
liposarcoma cell line:KMLS-1	10782-110G8	62.95	4.37	2.97	1.87	1.25	1.56	0.16
liposarcoma cell line:SW 872	10726-110A6	41.67	2.68	0.61	0.61	0.24	0.12	0.00
liver, adult, pool1	10018-101C9	53.48	1.94	2.59	0.32	0.16	0.00	0.00
liver, fetal, pool1	10086-102B5	45.15	2.82	3.76	3.76	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	58.04	1.02	3.21	4.52	1.17	0.29	0.44
locus coeruleus, adult, donor10252	10165-103B3	114.42	1.48	4.80	1.85	1.29	0.74	0.18
locus coeruleus, adult, donor10258	10375-105G6	59.25	3.95	3.67	4.23	3.10	1.69	0.28
locus coeruleus, newborn, donor10223	10362-105F2	71.51	0.84	2.52	5.47	1.68	0.84	0.42
lung adenocarcinoma cell line:A549	10499-107C4	156.94	74.87	8.30	0.97	4.71	1.94	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	32.40	8.27	0.00	0.00	0.00	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	63.27	5.54	0.66	0.40	1.19	0.79	0.13
lung, adult, pool1	10019-101D1	73.24	2.48	5.79	1.30	1.54	0.24	0.24
lung, fetal, donor1	10068-101I5	67.07	2.00	3.71	0.29	1.14	1.14	0.29
lung, right lower lobe, adult, donor1	10075-102A3	56.82	1.37	6.42	4.58	0.00	0.46	0.00
lymph node, adult, donor1	10077-102A5	53.96	7.57	13.73	1.89	0.95	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	49.31	2.85	2.19	0.44	0.66	1.10	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	31.54	9.81	0.91	0.45	0.15	0.30	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	46.72	6.80	0.85	0.85	1.70	1.70	0.00
mature adipocyte, donor1	12231-129F8	48.39	0.44	1.78	0.44	0.89	0.00	0.00
mature adipocyte, donor2	12232-129F9	60.39	2.49	1.25	0.21	0.42	0.00	0.00
mature adipocyte, donor3	12233-129G1	48.60	0.47	0.95	0.47	0.00	0.24	0.47
mature adipocyte, donor4	12234-129G2	56.85	1.05	1.05	0.00	0.26	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	73.38	6.43	1.19	0.24	0.24	0.48	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	67.68	1.13	5.64	2.26	1.13	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	95.08	0.55	3.31	3.86	1.10	0.18	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	48.61	0.00	2.54	1.91	1.27	0.64	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	66.53	3.41	2.56	2.56	0.43	0.85	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	63.28	0.84	2.87	12.66	1.35	5.74	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	93.17	0.21	2.55	9.55	1.06	0.21	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	69.35	1.93	0.00	1.93	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	100.48	0.00	14.35	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	65.33	1.79	2.15	2.51	1.44	0.00	0.36
medulla oblongata - adult, donor10196	10174-103C3	74.63	0.00	1.95	8.44	1.95	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	114.09	1.55	3.72	2.63	1.55	0.93	0.00
medulla oblongata, adult, pool1	10038-101F2	102.93	2.20	3.92	0.98	1.22	0.82	0.24
medulla oblongata, newborn, donor10223	10361-105F1	62.49	3.47	3.82	4.17	2.08	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	55.80	4.43	0.00	0.89	0.44	0.22	0.00
medulloblastoma cell line:ONS-76	10759-110E3	26.41	3.55	0.49	0.61	0.24	0.24	0.00
melanoma cell line:COLO 679	10514-107E1	51.17	4.17	0.57	0.43	0.29	0.29	0.00
melanoma cell line:G-361	10465-106H6	44.52	4.89	1.36	1.90	0.81	1.09	0.00
meningioma cell line:HKBMM	10691-109F7	38.89	3.44	1.45	1.81	0.54	0.72	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	61.68	14.10	0.88	2.64	0.00	3.52	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	68.69	5.44	1.81	2.33	1.04	1.04	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	44.65	2.30	1.99	1.23	0.61	0.92	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	48.72	2.54	1.27	0.36	0.55	1.64	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	36.03	2.90	1.66	1.24	0.41	0.83	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	95.94	27.25	18.68	1.55	3.79	2.25	2.95
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	71.25	7.51	5.97	1.54	1.35	2.12	2.12
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	49.28	12.49	13.19	1.39	3.47	2.08	2.78
mesenchymal precursor cell - cardiac, donor1	11752-123G6	50.98	3.26	2.23	0.69	1.03	1.20	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	49.11	3.22	1.38	1.38	0.12	1.61	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	50.67	2.65	2.39	0.40	0.93	1.99	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	63.74	8.10	3.92	1.22	0.95	3.11	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	60.75	4.98	3.84	0.57	1.56	2.56	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	53.36	1.98	2.96	1.32	0.66	0.99	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	52.03	1.66	1.66	1.11	0.83	0.42	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	48.52	4.89	5.24	1.75	1.05	2.09	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	44.71	1.43	2.25	1.43	0.61	0.82	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	29.48	2.16	0.72	1.08	0.00	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	42.41	0.83	1.45	1.34	0.83	1.34	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	44.46	5.93	3.65	1.37	1.82	0.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	91.04	12.59	7.55	2.52	1.68	3.36	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	45.58	2.69	3.14	1.20	1.05	1.05	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	47.97	2.89	1.14	0.88	0.70	1.14	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	35.71	1.84	1.84	1.47	0.74	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	38.06	3.15	3.72	1.14	0.00	1.14	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	34.10	4.21	0.42	4.63	0.84	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	38.36	3.65	2.28	0.46	0.46	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	36.32	2.30	3.33	1.02	0.77	1.53	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	35.86	2.36	2.09	1.31	1.05	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	39.44	1.85	1.85	0.92	1.23	1.54	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	38.83	2.12	3.06	0.94	0.94	1.41	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	46.37	1.02	2.37	1.35	1.02	0.68	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	42.83	2.36	1.57	0.79	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	50.05	1.85	3.71	1.39	1.85	0.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	58.55	2.02	2.31	0.58	1.15	0.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	47.30	2.23	1.56	0.89	0.89	0.67	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	43.74	2.16	3.36	2.16	0.48	1.20	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	43.27	2.93	5.13	1.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	40.95	2.01	3.02	0.34	1.34	0.67	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	37.25	2.46	0.82	1.64	0.82	0.82	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	44.24	3.87	1.29	0.86	1.29	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	32.81	0.00	5.47	5.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	5.16	5.16	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	35.73	0.97	2.92	1.30	0.97	1.95	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	43.65	0.00	0.00	2.91	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	31.98	3.20	3.20	2.13	1.60	1.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	28.62	0.82	2.45	2.45	2.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	37.32	1.55	1.94	1.55	0.78	2.33	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	46.17	6.30	0.00	6.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	36.76	3.97	1.99	1.99	0.00	1.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	0.00	9.53	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	35.58	2.96	2.96	1.19	1.19	2.37	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	36.55	2.44	3.66	1.22	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	31.04	0.00	4.43	0.63	0.63	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	38.63	3.45	3.45	1.72	0.69	1.03	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	23.64	0.00	2.15	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	3.99	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	51.66	0.00	0.00	3.44	0.00	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	35.04	1.63	2.85	1.63	0.81	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	27.81	0.79	2.38	2.38	0.79	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	37.14	1.77	1.18	3.54	0.00	1.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	39.27	0.62	1.25	0.62	0.00	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	45.45	0.00	2.67	4.01	0.00	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	21.29	0.00	1.18	4.73	1.18	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	46.22	2.57	2.57	10.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	41.99	3.44	0.69	2.75	0.00	2.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	45.03	0.99	0.49	1.98	0.49	1.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	45.98	1.12	0.00	2.24	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	29.89	0.64	0.64	1.91	0.64	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	43.12	0.40	0.81	1.61	0.40	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	61.06	0.00	2.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	36.74	0.00	2.53	0.00	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	47.34	1.21	0.61	1.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	36.15	0.00	0.00	4.52	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	42.01	0.82	1.65	2.47	0.82	3.29	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	35.72	0.99	0.79	0.79	0.40	0.20	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	34.07	0.65	1.62	0.32	0.32	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	29.54	1.02	0.00	3.06	0.00	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	14.70	0.00	3.09	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	108.91	14.17	1.89	2.60	1.65	0.71	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	43.32	2.32	1.16	0.23	0.23	0.46	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	51.28	12.82	4.27	4.27	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	35.86	7.40	1.34	3.49	0.51	1.13	0.10
mesothelioma cell line:Mero-25	10850-111F4	36.99	2.27	1.59	0.91	0.00	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	65.27	0.98	1.71	1.71	0.49	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	51.59	4.21	1.33	1.55	0.00	0.44	0.00
mesothelioma cell line:Mero-82	10853-111F7	63.60	9.72	2.10	2.37	0.00	1.84	0.00
mesothelioma cell line:Mero-83	10854-111F8	61.96	10.72	2.21	1.70	0.51	0.51	0.17
mesothelioma cell line:Mero-84	10855-111F9	74.57	1.26	1.77	2.02	1.01	0.76	0.00
mesothelioma cell line:Mero-95	10856-111G1	43.27	2.90	1.66	0.21	0.41	0.21	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	124.40	13.91	3.48	4.31	0.99	1.16	0.00
mesothelioma cell line:NCI-H226	10846-111E9	76.38	11.76	2.35	1.45	0.36	1.63	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	56.37	1.37	1.02	1.71	0.00	0.68	0.00
mesothelioma cell line:NCI-H28	10845-111E8	87.28	12.98	1.02	2.29	1.02	1.27	0.25
mesothelioma cell line:No36	10857-111G2	68.18	12.07	1.96	4.57	0.00	1.30	0.00
mesothelioma cell line:ONE58	10858-111G3	36.85	5.96	0.81	1.35	0.27	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	144.71	34.55	14.78	1.92	3.84	0.58	0.77
migratory langerhans cells, donor2	11902-125F3	102.45	26.99	11.60	1.34	4.76	0.98	0.85
migratory langerhans cells, donor3	11903-125F4	181.10	48.10	12.92	1.44	3.95	1.08	1.08
mixed mullerian tumor cell line:HTMMT	10689-109F5	33.30	3.59	0.00	4.90	0.98	5.55	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	57.65	9.11	3.60	2.54	2.33	1.48	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	44.46	8.75	2.07	0.69	0.92	0.46	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	35.77	1.71	1.71	0.57	0.57	0.00	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	42.50	6.65	0.55	0.55	0.18	0.55	0.00
myeloma cell line:PCM6	10474-106I6	40.13	6.33	10.87	1.78	2.17	2.77	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	17.76	3.04	0.51	1.52	0.51	1.01	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	38.64	3.92	0.00	0.78	0.39	1.18	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	132.04	16.49	9.92	1.34	1.34	0.22	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	117.00	15.52	8.24	0.81	0.81	0.59	0.00
nasal epithelial cells, donor2	12227-129F4	171.67	16.01	11.04	2.21	1.10	1.10	0.00
neuroblastoma cell line:CHP-134	10508-107D4	49.23	5.75	0.69	0.69	0.46	0.69	0.00
neuroblastoma cell line:NB-1	10539-107G8	73.71	5.05	2.25	0.37	1.12	0.75	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	51.04	2.74	0.42	1.48	0.42	1.05	0.00
neuroblastoma cell line:NH-12	10555-107I6	112.93	10.62	0.37	2.42	0.19	1.30	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	29.65	3.32	0.47	1.19	0.00	0.71	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	86.95	5.86	2.38	3.17	1.11	0.79	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	19.32	1.41	0.40	1.21	0.00	0.40	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	33.06	1.91	0.64	0.64	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	41.79	3.73	2.13	0.53	1.06	0.00	0.00
neutrophil PMN, donor1	12133-128D9	282.62	29.75	104.12	0.00	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	185.93	13.28	79.68	0.00	0.00	0.00	13.28
neutrophil PMN, donor3	12141-128E8	132.59	37.88	37.88	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	83.88	3.21	1.01	0.51	0.51	0.34	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	83.25	4.00	1.60	0.80	0.00	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	36.55	1.92	3.85	2.89	0.32	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	35.21	2.36	1.05	0.79	1.84	1.05	0.00
nucleus accumbens, adult, pool1	10037-101F1	92.90	0.75	2.72	0.66	1.50	0.37	0.37
occipital cortex - adult, donor10196	10172-103C1	86.54	0.00	6.18	6.18	0.00	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	108.42	2.95	3.22	9.93	0.54	0.81	0.00
occipital cortex, newborn, donor10223	10355-105E4	66.97	2.55	2.91	1.46	0.00	1.82	0.73
occipital lobe, adult, donor1	10076-102A4	70.59	1.05	2.62	3.15	0.79	1.31	0.26
occipital lobe, fetal, donor1	10073-102A1	156.19	5.15	4.29	7.72	7.29	0.86	2.15
occipital pole, adult, pool1	10036-101E9	66.07	0.47	1.73	0.16	0.71	0.08	0.00
olfactory region, adult	10195-103E6	69.16	0.38	0.38	2.67	0.19	0.57	0.00
optic nerve, donor1	10277-104E7	68.04	8.00	4.00	6.00	6.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	90.67	9.57	3.53	0.80	0.68	1.14	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	59.21	6.46	1.10	0.69	0.14	0.14	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	29.97	3.39	1.86	0.17	0.68	0.34	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	68.84	4.16	1.27	0.69	0.23	0.92	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	37.92	3.53	2.06	0.59	0.29	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	25.23	12.15	0.93	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	51.53	3.61	0.64	0.85	0.21	0.42	0.00
ovary, adult, pool1	10020-101D2	65.69	1.14	1.57	0.52	0.17	0.26	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	53.16	7.15	1.28	1.83	0.55	0.37	0.00
pancreas, adult, donor1	10049-101G4	73.37	1.88	4.70	0.94	0.94	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	57.30	7.27	0.56	1.40	0.84	0.56	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	31.34	5.96	0.85	1.70	0.34	1.53	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	74.02	8.94	3.97	0.33	0.83	1.66	0.17
paracentral gyrus, adult, pool1	10035-101E8	108.45	1.46	2.47	0.37	1.74	0.09	0.09
parietal cortex, adult, donor10258	10373-105G4	92.48	0.00	2.20	2.94	0.73	0.73	0.73
parietal lobe - adult, donor10196	10171-103B9	64.89	0.94	1.88	4.70	0.94	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	91.21	1.43	2.57	5.13	2.00	0.57	0.00
parietal lobe, adult, pool1	10034-101E7	96.23	0.62	2.29	0.88	1.23	0.26	0.09
parietal lobe, fetal, donor1	10072-101I9	128.02	1.94	7.76	9.70	3.88	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	56.45	2.62	2.99	4.11	0.75	0.37	0.75
parotid gland, adult	10199-103F1	64.75	2.47	8.02	0.00	1.85	0.00	0.62
penis, adult	10200-103F2	57.47	1.61	3.76	4.83	1.07	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	46.30	4.65	0.37	1.12	0.37	0.56	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	42.25	1.31	2.04	1.31	0.15	0.44	0.00
pineal gland - adult, donor10196	10179-103C8	37.41	0.00	2.58	1.94	0.00	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	81.13	0.00	4.74	2.37	0.59	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	47.03	0.00	0.00	1.25	1.25	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	67.79	0.00	1.01	2.02	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	115.70	0.52	2.08	2.08	0.52	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	55.33	0.85	0.85	0.00	0.85	0.00	0.85
placenta, adult, pool1	10021-101D3	51.06	0.54	1.94	0.54	0.43	0.00	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	55.75	3.84	0.79	1.32	0.40	0.40	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	41.71	4.82	1.09	1.56	0.16	1.87	0.31
pons, adult, pool1	10033-101E6	90.97	1.38	2.24	0.77	1.38	0.17	0.09
postcentral gyrus, adult, pool1	10032-101E5	73.14	0.78	2.09	0.96	0.70	0.17	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	79.47	31.37	8.37	0.00	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	27.54	11.02	0.00	0.00	0.00	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	58.68	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	92.93	6.12	2.18	2.62	1.46	1.75	0.00
prostate cancer cell line:PC-3	10439-106E7	69.15	6.90	1.09	3.63	1.27	1.82	0.18
prostate, adult, pool1	10022-101D4	66.93	0.91	2.18	0.82	0.45	0.09	0.09
putamen, adult, donor10196	10176-103C5	88.76	0.24	2.12	1.65	1.42	0.24	0.24
putamen, adult, donor10252	10152-102I8	43.14	0.00	5.88	0.00	0.00	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	71.03	5.46	2.19	1.09	2.19	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	56.54	0.24	2.17	1.21	1.69	0.48	0.00
putamen, newborn, donor10223	10365-105F5	71.22	3.00	3.75	0.75	2.25	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	43.64	5.82	1.45	0.29	1.45	0.58	0.00
rectum, fetal, donor1	10067-101I4	63.99	1.39	2.78	8.35	2.78	2.78	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	38.16	3.18	0.64	2.12	0.21	0.85	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	23.61	3.31	0.41	2.49	0.41	1.24	0.00
retina, adult, pool1	10030-101E3	58.15	0.60	0.60	0.30	0.50	0.20	0.10
retinoblastoma cell line:Y79	10475-106I7	34.81	3.38	0.26	0.52	0.00	1.30	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	38.24	2.58	1.23	0.61	0.61	0.49	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	49.77	2.53	0.00	0.00	0.84	1.12	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	17.43	0.76	0.76	0.76	0.76	0.76	0.00
salivary acinar cells, donor1	11771-123I7	77.04	15.38	8.90	2.91	1.94	0.81	0.16
salivary acinar cells, donor2	11772-123I8	59.48	5.78	14.04	1.10	1.38	0.69	0.00
salivary acinar cells, donor3	11773-123I9	59.58	9.93	47.01	1.32	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	67.49	2.86	9.15	0.00	3.43	0.57	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	52.44	2.61	1.43	1.10	0.76	0.93	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	53.49	2.70	1.29	2.70	0.59	0.71	0.00
seminal vesicle, adult	10201-103F3	44.97	1.06	4.23	3.17	0.53	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	38.14	1.21	2.43	1.21	0.00	1.46	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	57.12	3.27	2.01	1.26	0.00	0.50	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	72.25	4.01	5.02	5.02	0.00	4.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	74.82	4.16	0.94	2.55	0.13	0.94	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	71.62	6.74	2.32	1.22	0.66	0.99	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	113.80	52.51	17.55	1.94	1.81	1.03	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	51.07	3.55	0.71	4.26	2.13	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	100.03	4.20	1.68	1.32	0.60	0.48	0.00
skeletal muscle, fetal, donor1	10066-101I3	32.16	0.00	0.00	2.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	61.07	6.79	27.14	13.57	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	61.86	4.42	8.84	3.79	0.63	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	76.04	1.67	2.00	3.00	2.00	0.00	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	50.12	4.10	0.63	0.63	0.63	2.52	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	50.31	2.31	0.58	1.73	1.73	1.16	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	85.55	7.25	2.31	1.15	0.33	0.49	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	111.63	5.95	0.32	1.77	0.64	0.16	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	137.29	4.79	1.31	2.40	0.87	2.18	0.44
small intestine, adult, pool1	10024-101D6	97.23	1.67	9.08	0.84	1.07	0.24	0.24
small intestine, fetal, donor1	10064-101I1	54.79	1.23	1.47	2.21	0.00	0.25	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	29.75	4.10	2.05	1.03	0.51	1.03	0.00
smooth muscle, adult, pool1	10048-101G3	65.65	0.52	1.55	2.07	0.52	0.78	0.00
somatostatinoma cell line:QGP-1	10781-110G7	36.18	1.88	1.34	1.07	0.80	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	76.62	0.92	6.42	3.67	3.21	0.92	0.69
spinal cord, adult, donor10252	10159-103A6	133.26	5.52	7.89	3.94	3.55	0.79	0.00
spinal cord, adult, donor10258	10369-105F9	87.86	1.38	4.84	6.92	0.69	1.38	0.00
spinal cord, fetal, donor1	10056-101H2	103.06	1.83	5.49	7.32	1.83	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	97.81	2.76	4.13	2.30	4.13	1.38	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	49.59	3.58	4.03	1.79	1.34	0.60	0.15
spleen, adult, pool1	10025-101D7	86.46	13.11	13.99	0.88	1.32	0.22	0.11
spleen, fetal, pool1	10044-101F8	85.97	7.31	6.28	0.24	0.72	0.08	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	55.07	5.28	2.07	0.62	0.31	0.83	0.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	56.77	6.84	1.71	1.33	0.57	1.52	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	75.13	4.89	1.75	4.19	1.75	1.75	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	32.06	7.82	2.74	1.17	0.39	0.78	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	179.31	20.49	6.42	4.73	2.59	3.60	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	127.08	63.54	6.78	3.81	2.54	4.24	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	34.27	2.12	1.27	0.42	0.85	1.27	0.00
stomach, fetal, donor1	10062-101H8	52.33	0.00	7.48	0.00	1.07	1.07	0.00
submaxillary gland, adult	10202-103F4	75.77	1.71	5.13	1.71	1.14	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	217.10	0.00	0.00	54.27	0.00	108.55	0.00
substantia nigra, adult, donor10252	10158-103A5	144.98	2.28	4.57	3.12	1.25	1.66	0.21
substantia nigra, adult, donor10258	10371-105G2	72.93	2.07	2.07	2.07	2.59	1.03	0.52
substantia nigra, newborn, donor10223	10358-105E7	60.06	2.12	3.53	4.95	3.53	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	54.11	5.27	1.15	1.38	0.69	0.46	0.23
temporal lobe, adult, pool1	10031-101E4	65.02	0.51	1.78	0.59	1.10	0.25	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	151.00	4.99	3.56	4.99	6.41	2.14	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	136.26	3.08	3.52	3.52	5.71	0.88	0.00
tenocyte, donor1	11763-123H8	72.61	1.40	4.89	4.19	0.70	1.05	0.00
tenocyte, donor2	11765-123I1	70.96	4.58	6.49	2.29	0.76	2.67	0.38
tenocyte, donor3	11768-123I4	67.09	2.97	3.71	2.97	0.00	0.74	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	104.02	14.79	2.55	2.55	2.04	0.51	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	63.05	4.93	1.23	3.08	0.92	0.31	0.00
teratocarcinoma cell line:PA-1	10807-111A6	67.26	4.65	2.01	1.39	1.70	0.62	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	51.41	13.96	2.92	1.14	1.02	0.63	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	57.86	15.88	0.76	1.13	1.13	1.51	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	68.05	14.40	2.18	1.31	1.09	1.20	0.44
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	71.00	17.26	0.98	2.28	1.30	1.63	0.33
testis, adult, pool1	10026-101D8	67.22	1.40	2.36	0.86	1.93	0.32	0.11
testis, adult, pool2	10096-102C6	85.71	2.71	0.90	3.16	1.80	1.80	1.35
thalamus - adult, donor10196	10168-103B6	107.09	1.10	3.31	5.52	1.10	0.00	0.00
thalamus, adult, donor10252	10154-103A1	129.87	1.25	3.28	3.13	1.88	1.09	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	81.60	3.08	1.54	1.54	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	48.42	0.99	2.31	2.64	0.99	1.81	0.00
thalamus, newborn, donor10223	10366-105F6	56.38	2.88	5.75	6.33	2.30	0.58	0.00
throat, adult	10209-103G2	114.35	29.21	26.22	1.00	1.50	1.00	0.00
throat, fetal, donor1	10061-101H7	61.25	0.91	1.83	3.35	0.91	1.83	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	43.72	2.38	0.00	2.58	0.99	0.79	0.00
thymus, adult, pool1	10027-101D9	79.03	6.26	3.68	0.89	1.59	0.30	0.40
thymus, fetal, pool1	10043-101F7	83.75	4.99	4.68	0.73	1.35	0.21	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	56.11	6.52	2.26	2.93	0.66	1.20	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	38.41	1.54	0.28	0.98	0.14	0.42	0.00
thyroid, adult, pool1	10028-101E1	99.66	1.40	2.33	1.40	0.47	0.47	0.00
thyroid, fetal, donor1	10060-101H6	95.97	6.33	5.54	4.75	1.58	1.85	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	58.51	15.40	15.40	3.08	3.08	0.00	0.00
tongue, adult	10203-103F5	139.55	50.93	35.82	4.42	2.79	1.63	1.63
tongue, fetal, donor1	10059-101H5	111.53	10.64	29.16	3.94	1.18	1.97	0.00
tonsil, adult, pool1	10047-101G2	139.04	36.46	37.87	1.00	1.90	0.50	0.30
trachea, adult, pool1	10029-101E2	101.68	14.89	13.17	0.98	1.23	0.41	0.16
trachea, fetal, donor1	10058-101H4	76.94	2.31	8.46	3.46	0.77	1.54	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	41.10	2.83	2.48	1.06	0.71	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	42.45	6.38	1.11	0.51	0.71	0.71	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	55.62	1.88	0.31	1.57	0.78	0.31	0.00
tridermal teratoma cell line:HGRT	10694-109G1	15.22	3.81	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	56.46	5.08	2.62	1.10	1.27	0.08	0.00
umbilical cord, fetal, donor1	10057-101H3	54.25	0.00	0.00	0.00	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	65.52	0.85	2.73	0.51	0.34	0.17	0.00
uterus, fetal, donor1	10055-101H1	85.49	3.07	22.01	4.61	1.02	0.51	0.00
vagina, adult	10204-103F6	76.25	0.00	4.52	0.00	0.65	0.00	0.00
vein, adult	10191-103E2	49.32	2.19	5.48	0.44	1.10	0.22	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	39.79	2.94	0.53	0.27	0.27	0.00	0.53